{
  "meta": {
    "title": "Heart_Failure_And_Shock",
    "url": "https://brainandscalpel.vercel.app/heart-failure-and-shock-8e00202e.html",
    "scrapedAt": "2025-11-30T14:11:43.198Z"
  },
  "questions": [
    {
      "text": "A 66-year-old nonbinary individual presents to the emergency department for evaluation of shortness of breath with exertion. The patient reports increasing shortness of breath over the past several weeks to the point where they can no longer climb a flight of stairs without becoming winded. Past medical history includes hypertension, hyperlipidemia, and deep vein thrombosis following a knee replacement surgery ten years ago. The patient has not seen a physician in years and is currently not on any medications. They currently smoke one pack of cigarettes daily. Temperature is 36.1&#176;C (97.0&#176;F), pulse is 78/min, respirations are 22/min, blood pressure is 188/92 mmHg, and O2 saturation is 91% on room air. Physical examination demonstrates an additional heart sound heard just after S2, and diffuse rales on lung auscultation. Jugular venous distension, pitting edema, and hepatomegaly are absent. A chest X-ray is obtained and demonstrated below. Which of the following best describes the pathophysiology of this patient&#8217;s pulmonary findings? &#160;<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/R6XFqXxGSTKBQlXUuZ-2idyyQF2auN3C/_.jpg\"></div><br>Image reproduced from Wikimedia Commons",
      "choices": [
        {
          "id": 1,
          "text": "Increased pulmonary venous pressure"
        },
        {
          "id": 2,
          "text": "Decreased pulmonary venous pressure&#160;"
        },
        {
          "id": 3,
          "text": "Increased central venous pressure&#160;"
        },
        {
          "id": 4,
          "text": "Decreased pulmonary capillary wedge pressure"
        },
        {
          "id": 5,
          "text": "Recurrent pulmonary embolism"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient presents with clinical features consistent with <strong>left-heart failure&#160;</strong>including an S3 gallop and pulmonary edema. The primary pathophysiology underlying pulmonary edema secondary to left-sided heart failure is an<strong>&#160;increase in pulmonary venous pressure</strong> and subsequent<strong>&#160;transudation of fluid into the lung parenchyma.&#160;</strong>&#160;<br><br>Left-sided heart failure refers to anatomical failure of the left-side of the heart only and presents with characteristic symptoms and examination findings. Notably, patients present with <strong>orthopnea&#160;</strong>(shortness of breath when lying supine), <strong>paroxysmal nocturnal dyspnea&#160;</strong>(breathless awakening from sleep), and <strong>pulmonary edema</strong>. The former two findings are largely due to <strong>increased venous return</strong> and <strong>redistribution of blood&#160;</strong>when lying flat, whereas pulmonary edema results from impaired forward arterial blood flow and vascular congestion. &#160; <br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/PuTgVO-9R8i6oDmlXTf9dPzhRT6ztToV/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Increased pulmonary venous pressure:</strong><br><span style='opacity:0.9'><strong>Correct:&#160;</strong>See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Decreased pulmonary venous pressure&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Increased, not decreased, pulmonary venous pressure likely underlies this patient&#8217;s pulmonary findings. With left-sided heart failure, poor ejection fraction manifests with increased pulmonary capillary wedge pressure, increased pulmonary venous pressure, and subsequent transudation of fluid into the lung parenchyma.</span></div><div style='margin-bottom: 12px;'><strong>❌ Increased central venous pressure&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Increased central venous pressure occurs in the setting of right heart failure. Right heart failure can manifest with pitting edema, hepatosplenomegaly, and jugular venous distension. In contrast, these findings are absent in this patient.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Decreased pulmonary capillary wedge pressure:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Increased, not decreased, pulmonary capillary wedge pressure leads to the development of pulmonary edema. &#160;&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Recurrent pulmonary embolism:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>While this patient has a history of a remote deep vein thrombosis, he has no evidence of right heart failure on examination. This patient&#8217;s pulmonary findings are more likely secondary to left-sided heart failure and a different underlying etiology.&#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 70-year-old woman comes to the emergency department due to a three week history of worsening fatigue, dyspnea on exertion, and lower extremity swelling. Her past medical history is significant for hypertension and hyperlipidemia, but notes no recent travel, sick contacts, or illnesses. She recalls one episode of nausea and diaphoresis while she was lifting boxes at home approximately one month ago, but she does not recall any chest pain or shortness of breath at that time. She is a life-time non-smoker and reports drinking one glass of wine every night with dinner. Her temperature is 37.2&#176;C (98.9&#176; F), pulse is 75/min, respirations are 18/min, and blood pressure is 142/82 mmHg. Physical examination shows 2+ pitting edema of the lower extremities and prominent jugular veins. An additional heart sound is heard just after S2, and faint bibasilar crackles are heard on auscultation of the lungs. Transthoracic echocardiography demonstrates a dilated left ventricle and increased end-diastolic volume, and wall motion abnormalities are noted along the anterolateral heart border. Ejection fraction by visualization is estimated at 34%. Which of the following best describes the underlying cause of this patient&#8217;s symptoms?",
      "choices": [
        {
          "id": 1,
          "text": "Long-standing untreated hypertension"
        },
        {
          "id": 2,
          "text": "Ischemic heart disease"
        },
        {
          "id": 3,
          "text": "Repetitive vasoconstriction of pulmonary vasculature"
        },
        {
          "id": 4,
          "text": "Alcohol consumption"
        },
        {
          "id": 5,
          "text": "Infection with a positive-sense single-stranded RNA virus"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<strong>Systolic heart failure</strong> is most commonly due to <strong>ischemia</strong> or <strong>myocardial infarction</strong>, which causes decreased cardiac contractility that leads to systolic dysfunction. The inability of the heart to effectively pump blood forward through circulation results in clinical features of left-sided heart failure causing pulmonary edema: <strong>fatigue, dyspnea, orthopnea, paroxysmal nocturnal dyspnea</strong>, as well as <strong>bibasilar crackles</strong> and an <strong>S3 heart sound (ventricular gallop)</strong> on examination. This often progresses to right-sided heart failure, resulting in <strong>jugular venous distention (JVD), pitting edema,</strong> and <strong>hepatic congestion</strong>. The patient in this question likely suffered an atypical or silent myocardial infarction while she was moving boxes several weeks ago, and without appropriate treatment, she has now developed systolic heart failure. Other causes of systolic heart failure include etiologies of dilated cardiomyopathy including alcohol, coxsackie B virus infection, chronic cocaine use, or Chagas disease. Echocardiography typically shows an <strong>increased end diastolic volume (EDV), decreased contractility</strong> (or wall motion abnormalities), and <strong>reduced ejection fraction (EF)</strong>.<br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/uAs85iIiSUalZSblNaQJQPbTTpWahNv7/_.png\"></div><br>In contrast to systolic heart failure, <strong>diastolic heart failure</strong> is most commonly due to <strong>cardiac hypertrophy</strong> from long-standing, <strong>untreated hypertension</strong>. It presents with the same clinical features as systolic heart failure. Echocardiographic findings generally demonstrate a <strong>preserved EF</strong> and a <strong>normal EDV</strong>. Patients with diastolic heart failure will also have <strong>decreased compliance (increased end diastolic pressure)</strong> due to stiff ventricular walls. Other etiologies of diastolic heart failure include infiltrative diseases such as amyloidosis, sarcoidosis, or post-radiation fibrosis.<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Long-standing untreated hypertension:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Long standing untreated hypertension typically results in findings of diastolic heart failure due to concentric hypertrophy. Findings include a preserved ejection fraction and a normal end-diastolic volume. The patient in this vignette has an increased end diastolic volume and a reduced ejection fraction making an etiology of systolic heart failure more likely.</span></div><div style='margin-bottom: 12px;'><strong>✅ Ischemic heart disease:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Repetitive vasoconstriction of pulmonary vasculature:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: This answer choice describes the pathophysiology of chronic smoking and COPD leading to cor pulmonale or isolated right sided heart failure. Prolonged vasoconstriction of pulmonary vasculature increases demand on the right heart, eventually leading to peripheral edema and hepatic congestion without pulmonary edema. The patient in this vignette has findings of pulmonary edema and is not a smoker, making this diagnosis less likely.</span></div><div style='margin-bottom: 12px;'><strong>❌ Alcohol consumption:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Alcohol can cause dilated cardiomyopathy and systolic heart failure; however, this occurs only with heavy consumption. The patient in this vignette is described as consuming within the recommended drink limit per day, making this diagnosis unlikely.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Infection with a positive-sense single-stranded RNA virus:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: This question stem describes the pathophysiology of a dilated cardiomyopathy from coxsackie B virus, which can cause systolic heart failure (as seen in this patient). This answer choice is less likely in this patient without a recent history of infectious illness. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 78-year-old male presents to the emergency department with altered mental status and fatigue. He is found to be critically ill and is admitted to the intensive care unit (ICU) for further evaluation and monitoring. While in the ICU, the patient has a Swan-Ganz catheter placed in the right heart for continuous hemodynamic measurements. An initial set of readings is demonstrated below:<br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/ADCXuWP5QviR6XQ8__Yb4hylT2_By9NW/_.png\"></div><br><br>Which of the following is the most likely cause of this patient's clinical presentation?",
      "choices": [
        {
          "id": 1,
          "text": "Heart failure"
        },
        {
          "id": 2,
          "text": "Bacteremia due to a Gram-negative rod"
        },
        {
          "id": 3,
          "text": "Impaired sympathetic outflow"
        },
        {
          "id": 4,
          "text": "Thrombus in the pulmonary artery"
        },
        {
          "id": 5,
          "text": "Hemorrhage due to bleeding peptic ulcer"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This critically ill patient had a <strong>Swan-Ganz catheter</strong> placed and hemodynamic measurements taken. The findings include a decreased cardiac output (of which the cardiac index is a surrogate measure taking into account BMI), increased systemic vascular resistance, increased pulmonary capillary wedge pressure (PCWP), and decreased mixed venous oxygen saturation (SvO<sub>2</sub>). These parameters are consistent with <strong>cardiogenic shock</strong>, of which <strong>heart failure</strong> is a common etiology. &#160; <br><br>A <strong>Swan-Ganz catheter</strong> is a flexible tube passed into the right side of the heart and the pulmonary artery. It is used to take measurements of cardiac output (heart x stroke volume), systemic vascular resistance (80x (Mean Arterial Pressure - Mean Venous Pressure or CVP) / Cardiac Output), PCWP (surrogate of left atrial pressure), and SvO<sub>2</sub> (measure of total body oxygen consumption). While seldom used in modern ICUs, it was historically used to provide useful information in determining the etiology of a patient&#8217;s shock. &#160;<br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/C1PVduSXQH6QSFFOecIFxKy9TOqgcWbI/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Heart failure:</strong><br><span style='opacity:0.9'><strong>Correct:</strong> See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Bacteremia due to a Gram-negative rod:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Septic shock is a subtype of distributive shock that presents with decreased systemic vascular resistance, decreased pulmonary capillary wedge pressure, increased cardiac output, and increased mixed venous oxygen saturation. This patient&#8217;s findings are inconsistent with those of septic shock.</span></div><div style='margin-bottom: 12px;'><strong>❌ Impaired sympathetic outflow:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Neurogenic shock is another subtype of distributive shock that presents with decreased systemic vascular resistance, decreased pulmonary capillary wedge pressure, decreased cardiac output, and an increased mixed venous oxygen saturation. It is most commonly caused by spinal cord injury that disrupts sympathetic outflow. In contrast, this patient has an elevated systemic vascular resistance.</span></div><div style='margin-bottom: 12px;'><strong>❌ Thrombus in the pulmonary artery:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Obstructive shock is a subtype of &#8220;cold shock&#8221; and can be caused by pulmonary embolism. It can present with increased systemic vascular resistance, decreased cardiac output, and decreased mixed venous oxygen saturation. In causes of obstructive shock secondary to pulmonary embolism, pulmonary capillary wedge pressure (surrogate of left atrial pressure) is reduced since less blood is reaching the left heart.</span></div><div style='margin-bottom: 12px;'><strong>❌ Hemorrhage due to bleeding peptic ulcer:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Hemorrhagic shock presents with increased systemic vascular resistance, decreased pulmonary capillary wedge pressure, decreased cardiac output, and decreased mixed venous oxygen saturation. It is most commonly due to ongoing hemorrhage from trauma or gastrointestinal bleeding.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 52-year-old female presents to the emergency department with chest pain and shortness of breath. She currently lives in a rehabilitation facility, where she is undergoing rehabilitation after having a total hip replacement. Past medical history is notable for COPD, type II diabetes mellitus, osteoarthritis, and hypertension. Temperature is 37.0&#176;C (98.6&#176;F), pulse is 132/min, respirations are 28/min, blood pressure is 84/60 mmHg, and O2 saturation is 76% on room air. On physical exam, the patient is in respiratory distress with clammy and cool extremities. Cardiopulmonary exam is notable for jugular venous distension but is otherwise unremarkable. ECG is demonstrated below:<br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/Z_-48VcDQsWItotDTnmQVDe-RDeDm4IN/_.jpg\"></div><br><sup>Image reproduced from Wikimedia Commons<br></sup><br>Which of the following best describes the underlying pathophysiology of this patient&#8217;s clinical presentation?",
      "choices": [
        {
          "id": 1,
          "text": "V/Q mismatch"
        },
        {
          "id": 2,
          "text": "Decreased venous return"
        },
        {
          "id": 3,
          "text": "Systemic release of histamine and associated inflammatory mediators"
        },
        {
          "id": 4,
          "text": "Occlusion of the right coronary artery"
        },
        {
          "id": 5,
          "text": "Left ventricular outflow obstruction"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient has profound hypotension, hypoxemia, and cool clammy extremities in the setting of a recent surgery and prolonged immobilization. Her overall clinical presentation is consistent with a <strong>massive pulmonary embolism</strong> resulting in <strong>obstructive shock</strong> and <strong>ventilation perfusion mismatch</strong>. Her presentation warrants consideration for treatment with <strong>thrombolytic therapy</strong>, which will break down the thrombus. &#160; <br><br><strong>Obstructive shock</strong> described impaired end-organ perfusion due to physical obstruction of circulation either into or out of the heart. It falls under the umbrella of &#8220;cold shock&#8221;, which manifests with clammy and cool extremities due to decreased cardiac output and increased systemic vascular resistance to shunt blood towards vital organs. &#160; <br><br>There are three primary causes of obstructive shock: <strong>pulmonary embolism</strong>, <strong>pericardial tamponade</strong>, and <strong>tension pneumothorax</strong>. A pulmonary embolism manifests with obstructive shock due to the right heart's inability to pump blood through the pulmonary vasculature, causing profound V/Q mismatch, jugular venous distension, hypoxemia, and compromised left ventricular cardiac output. Pericardial tamponade refers to accumulation of blood or fluid in the pericardial sac, of which there are numerous causes including trauma, uremia, and pericarditis. When the amount of pericardial fluid reaches a critical threshold, ventricular filling and outflow becomes compromised, warranting pericardiocentesis. Lastly, a tension pneumothorax results in compression of mediastinal structures and causes decreased venous return and stroke volume. Treatment involves rapid decompression with needle thoracostomy followed by chest tube placement.<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/NkRMU33URP2Lg4nuWDA_Ld7TQGawJ_ZI/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ V/Q mismatch:</strong><br><span style='opacity:0.9'><strong>Correct:</strong> See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Decreased venous return:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Hypovolemic shock is associated with decreased venous return to the heart. This patient&#8217;s clinical presentation of chest pain and shortness of breath in the setting of a recent surgery is more consistent with pulmonary embolism, which results in a ventilation perfusion deficit.</span></div><div style='margin-bottom: 12px;'><strong>❌ Systemic release of histamine and associated inflammatory mediators:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Anaphylaxis falls under the category of distributive or &#8220;warm&#8221; shock and is due to systemic release of histamine as well as other inflammatory mediators. Unlike obstructive shock, which is associated with cool extremities, anaphylaxis is associated with warm extremities. Additional clues for anaphylactic shock include a history of exposure to an allergen (e.g. bee sting) or presence of a diffuse erythematous rash.</span></div><div style='margin-bottom: 12px;'><strong>❌ Occlusion of the right coronary artery:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Cardiogenic shock can result from occlusion of the right coronary artery. This type of shock may manifest with right ventricular failure, jugular venous distension, and lethal arrhythmias resulting in compromised cardiac output. Occlusion of the right coronary artery manifests with ST-elevations in leads II, III, and aVF. This patient&#8217;s electrocardiogram demonstrates sinus tachycardia, making this diagnosis unlikely.</span></div><div style='margin-bottom: 12px;'><strong>❌ Left ventricular outflow obstruction:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Pericardial tamponade is a type of obstructive shock that can cause left ventricular outflow obstruction. Clues to this diagnosis include a history of penetrating trauma to the chest, uremia, malignancy, and presence of Beck triad (muffled heart tones, jugular venous distension, and hypotension). An ECG will typically demonstrate &#8220;electrical alternans&#8221; due to the oscillations of the heart within the pericardium.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 52-year-old-male presents to the emergency department with increased work of breathing. He was walking to his car when he suddenly became short of breath. Past medical history includes diabetes, hypertension, and a twenty pack year smoking history. Temperature is 37.0&#176;C (98.6&#176;F), pulse is 121/min, respirations are 24/min, blood pressure is 87/60 mmHg, and O2 saturation is 93% on room air. On physical examination, the patient is, in moderate respiratory distress, and has his left hand held over the sternum. Cardiopulmonary exam is notable for bilateral rales without gallops, rubs, or murmurs. Distal extremities are cool to the touch. The patient&#8217;s chest x-ray and electrocardiogram are demonstrated below:<br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/9ksKquLyQbC0tncdpXpDwvtYSx6qXOlR/_.png\"></div><br>Image reproduced from <br><br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/UJHRXF_RSlOR9sKYHKU17cZYSx2OvanG/_.jpg\"></div><br>Image reproduced from<br><br>Which of the following is the most likely etiology of this patient&#8217;s clinical findings?",
      "choices": [
        {
          "id": 1,
          "text": "Occlusion of the left anterior descending coronary artery"
        },
        {
          "id": 2,
          "text": "Large thrombus in the pulmonary artery"
        },
        {
          "id": 3,
          "text": "Systemic release of histamine and associated inflammatory mediators"
        },
        {
          "id": 4,
          "text": "Disseminated infection due to a Gram positive cocci"
        },
        {
          "id": 5,
          "text": "Lung collapse and tension physiology"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient has respiratory distress, Levine sign (a clenched fist held over the chest commonly associated with anginal chest pain), hemodynamic instability, and cool extremities consistent with <strong>&#8220;cold shock.&#8221;</strong>&#160; The differential diagnosis for cold shock includes <strong>obstructive shock</strong>, <strong>cardiogenic shock</strong>, and <strong>hypovolemic shock</strong>. Clues to elucidate the subtype of cold shock rests on clinical history, as well as laboratory, imaging, and electrocardiographic findings. For example, this patient has an ECG demonstrating ST-elevations in the antero-lateral leads and a chest x-ray demonstrating acute pulmonary edema. Together, these clinical findings are consistent with <strong>cardiogenic shock</strong>, of which the most common cause is <strong>acute myocardial infarction</strong>. &#160; <br><br><strong>Cardiogenic shock</strong> refers to inadequate systemic organ perfusion that arises due to cardiac dysfunction. Etiologies include myocardial infarction, congestive heart failure, valvular dysfunction, and myocardial contusion. When cardiac myocytes suffer an insult, cardiac output diminishes, and peripheral vascular beds vasoconstrict to increase systemic vascular resistance and divert blood flow to central organs (e.g., heart, kidneys). Due to this shift in vascular flow, patients develop <strong>cold peripheral extremities</strong>, <strong>pallor</strong>, and <strong>clammy skin</strong>. Additionally, the heart's diminished ability to pump blood forward causes pooling of blood in the pulmonary vasculature, resulting in <strong>acute pulmonary edema</strong> and an <strong>increased pulmonary capillary wedge pressure</strong>. &#160; <br><br>Treatment of cardiogenic shock is dependent on the underlying cause (e.g. revascularization in the case of acute myocardial infarction). In the interim, medications and support devices can be used to assist the patient&#8217;s physiology. For instance, inotropic medications and mechanical support devices (e.g. intra-aortic balloon pump) are often utilized. &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Occlusion of the left anterior descending coronary artery:</strong><br><span style='opacity:0.9'><strong>Correct:&#160;</strong>See Main Explanation.<br></span></div><div style='margin-bottom: 12px;'><strong>❌ Large thrombus in the pulmonary artery:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>A large pulmonary embolus is in the differential of obstructive shock and results in hemodynamic compromise due to profound ventilation perfusion mismatch. A large pulmonary embolism can present with a normal chest radiograph, hypoxemia, and an S1Q3T3 pattern on electrocardiogram. However, the condition would not present with ST segment elevation in V1-V5.</span></div><div style='margin-bottom: 12px;'><strong>❌ Systemic release of histamine and associated inflammatory mediators:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Anaphylaxis falls under the category of distributive or &#8220;warm&#8221; shock. It arises due to systemic release of histamine and other inflammatory mediators. Unlike cardiogenic shock, which is associated with cool extremities, anaphylaxis is associated with warm extremities. Additional clues for anaphylactic shock include a history of exposure to an allergen (e.g. bee sting) or presence of a diffuse erythematous rash. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Disseminated infection due to a Gram positive cocci:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Sepsis falls under the category of distributive or &#8220;warm&#8221; shock. The most common cause of septic shock is bacterial pneumonia, which tends to demonstrate a focal consolidation on chest x-ray, as opposed to the diffuse interstitial pattern seen on this patient&#8217;s x-ray. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Lung collapse and tension physiology:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Tension pneumothorax can cause obstructive shock via compression of mediastinal structures, resulting in impaired venous return and aortic outflow obstruction. This patient has no evidence of pneumothorax on the chest x-ray. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "An 87-year-old male is brought to the emergency department with worsening shortness of breath. Per paramedics, the patient was found down at his assisted living facility with increased work of breathing. Yesterday, the patient was in no acute distress but was noted by nursing staff to be acting &#8220;more confused&#8221; than usual. The patient&#8217;s past medical history is notable for coronary artery disease, hypertension, and type II diabetes mellitus. Temperature is 38.9&#176;C (102&#176;F), pulse is 140/min, respirations are 32/min, blood pressure is 79/50 mmHg, and O2 saturation is 89% on room air. On physical exam, the patient is obtunded, ill appearing, and has both suprasternal and intercostal retractions. Laboratory findings are demonstrated below:<br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/nArwPqVdTA2suD3ye6vBLO9ySvmWrX9M/_.png\"></div><br><br>This patient is likely to have which of the following additional clinical findings?",
      "choices": [
        {
          "id": 1,
          "text": "Perfused peripheral extremities"
        },
        {
          "id": 2,
          "text": "Delayed capillary refill"
        },
        {
          "id": 3,
          "text": "Muffled heart sounds"
        },
        {
          "id": 4,
          "text": "Bilateral pulmonary rales"
        },
        {
          "id": 5,
          "text": "Jugular venous distension"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This elderly patient presents with increased work of breathing, fever, hypotension, and lactic acidosis. His overall clinical presentation is consistent with <strong>septic shock</strong> and hypoxemic respiratory failure, likely in the setting of community acquired pneumonia. Septic shock falls under the umbrella of <strong>distributive or &#8220;warm shock,&#8221;</strong> which presents with <strong>warm</strong>, <strong>perfused peripheral extremities</strong>. &#160; <br><br>Distributive shock refers to severe peripheral vasodilation resulting in inadequate perfusion to vital organs. There are three primary causes of distributive shock: <strong>sepsis</strong>, <strong>anaphylaxis</strong>, and <strong>neurogenic</strong>. &#160;Overall, septic shock is the most common cause and refers to a systemic physiologic response to severe infection. Anaphylaxis refers to an extreme systemic response to allergens. Neurogenic shock refers to impaired sympathetic outflow in response to severe neurological trauma. &#160; <br><br>Regardless of etiology, the overall clinical and physiologic presentation of distributive shock is similar. Profound peripheral vasodilation results in <strong>decreased systemic vascular resistance</strong>, <strong>decreased venous return</strong>, and <strong>decreased pulmonary capillary wedge pressure</strong>. In response, the heart compensates by <strong>increasing cardiac output</strong> (via increased heart rate) in an attempt to perfuse vital organs. However, as blood moves faster through capillary beds, the tissues cannot extract the necessary oxygen needed to perform metabolic functions. This phenomenon results in <strong>increased anaerobic metabolism</strong>, <strong>lactic acidosis</strong>, and <strong>increased mixed venous oxygen saturation</strong>. &#160;<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/NqMkNurBQueZInGz3DIfeL1NQRKualoB/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Perfused peripheral extremities:</strong><br><span style='opacity:0.9'><strong>Correct:</strong> See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Delayed capillary refill:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> &#8220;Cold shock&#8221; presents with cool extremities and is most commonly associated with cardiogenic, obstructive, or hypovolemic shock. These etiologies are less likely in this patient who is febrile and has a metabolic acidosis. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Muffled heart sounds:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Patients with pericardial tamponade, a type of obstructive shock, can present with Beck triad. Beck triad consists of muffled heart sounds, jugular venous distention, and hypotension. Clues to this diagnosis include a history of penetrating trauma to the chest, uremia, or malignancy. In contrast, this patient has fever, altered mental status, and metabolic acidosis, which raises greater concerns for infection and sepsis.</span></div><div style='margin-bottom: 12px;'><strong>❌ Bilateral pulmonary rales:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Cardiogenic shock often presents with pulmonary edema due to decreased cardiac output, increased pulmonary capillary wedge pressure, and subsequent pooling of blood in the pulmonary vasculature. This patient&#8217;s presentation is more consistent with sepsis secondary to community acquired pneumonia, which typically presents with <em>unilateral&#160;</em>rales.</span></div><div style='margin-bottom: 12px;'><strong>❌ Jugular venous distension:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Obstructive shock, which may be due to cardiac tamponade, tension pneumothorax, or pulmonary embolism, falls under the umbrella of &#8220;cold shock.&#8221; These conditions can present with jugular venous distension due to impaired cardiac outflow.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "&#160;76-year-old woman presents to the emergency department for evaluation of increased lower extremity swelling and shortness of breath. The patient has had progressive lower extremity swelling over the past several weeks to the point where she can no longer fit into her normal shoe size. In addition, she can no longer walk half a city block before becoming short of breath. Past medical history includes hypertension, diabetes, and a deep vein thrombosis after a long flight ten years ago. The patient has been smoking one pack of cigarettes per day for thirty-five years. Temperature is 36.1&#176;C (97.0&#176;F), pulse is 78/min, respirations are 16/min, blood pressure is 156/92 mmHg, and O2 is 90% on room air. Physical examination demonstrates a loud P2, jugular venous distension, faint bilateral end-expiratory wheezing, and 2+ pitting edema in the bilateral lower extremities. A chest X-ray is obtained and shown below. Which of the following best describes the pathophysiology of this patient&#8217;s lower extremity findings? &#160;<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/gzAwxy0TSlKqThP7_mz94p2YTaGoECIJ/_.jpg\"></div><br>Image reproduced from Wikimedia Commons&#160; ",
      "choices": [
        {
          "id": 1,
          "text": "Increased venous hydrostatic pressure and fluid transudation &#160;"
        },
        {
          "id": 2,
          "text": "Decreased venous oncotic pressure and fluid transudation"
        },
        {
          "id": 3,
          "text": "Impaired lymphatic drainage"
        },
        {
          "id": 4,
          "text": "Increased pulmonary venous pressure"
        },
        {
          "id": 5,
          "text": "Recurrent deep vein thrombosis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient with a significant smoking history presents with <strong>peripheral edema, jugular venous distension,</strong> and a<strong>&#160;loud P2</strong> on auscultation. These findings, in the absence of features of left-sided heart failure (e.g., orthopnea, paroxysmal nocturnal dyspnea, pulmonary edema), favor the diagnosis of <strong>cor pulmonale</strong>. Cor pulmonale refers to <strong>isolated right heart failure</strong> (RHF) secondary to a pulmonary condition. &#160; <br><br>Chronic obstructive pulmonary disease and other lung diseases can cause<strong>&#160;pulmonary hypertension&#160;</strong>and subsequent <strong>right ventricular hypertrophy</strong> that leads to isolated <strong>right heart failure</strong> (RHF), or cor pulmonale. In cor pulmonale, the right heart cannot overcome the pressure within the pulmonary circulation, and the backward pressure leads to <strong>jugular venous distention, increased portal blood pressure</strong>, and <strong>peripheral edema</strong>. Increased pressure in the portal system can manifest with h<strong>epatosplenomegaly, hepatic pulsation, ascites</strong>, and, in severe cases, <strong>cardiac cirrhosis</strong> (i.e., liver cirrhosis due to cardiac causes). In the lower extremities, increased venous hydrostatic pressure overcomes venous oncotic pressures. These changes result in transudation of fluid into the surrounding tissues and subsequent lower extremity edema. &#160; <br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/wv2VEToKQl62GkEwFC1dlRi0S1CAqbpS/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Increased venous hydrostatic pressure and fluid transudation &#160;:</strong><br><span style='opacity:0.9'><strong>Correct: </strong>See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Decreased venous oncotic pressure and fluid transudation:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Decreased venous oncotic pressures may also result in lower extremity edema and are characteristic of low protein states, such as cirrhosis or nephrotic syndrome. However, this patient&#8217;s history and physical examination do not suggest underlying liver or renal disease states.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Impaired lymphatic drainage:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Impaired lymphatic drainage, such as in the case of a pelvic or abdominal malignancy, may result in lower extremity edema. However, this patient&#8217;s presentation is more consistent with COPD and cor pulmonale.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Increased pulmonary venous pressure:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Increased pulmonary venous pressures are associated with left-sided heart failure and pulmonary edema. This patient has an unremarkable chest radiograph and no evidence of pulmonary edema.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Recurrent deep vein thrombosis:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>While this patient has a remote history of a deep vein thrombosis (DVT), she has evidence of bilateral lower extremity swelling. Bilateral DVTs are incredibly rare and typically occur in the setting of critical illness. Cor pulmonale is a more realistic explanation for her lower extremity findings.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 24-year-old female presents to the emergency department with shortness of breath. She is accompanied by her college-roommate, who reports she found the patient wheezing in her room. The patient is unable to provide additional history due to her labored work of breathing. Temperature is 37.0&#176;C (98.6&#176;F), pulse is 115 min, respirations are 28/min, blood pressure is 90/60 mmHg, and O<sub>2</sub> saturation is 90% on room air. On physical exam, the patient has diffuse wheezing throughout the lung fields as well as a diffuse erythematous macular rash over the chest wall. The posterior pharynx is not visualized due to severe lip and tongue swelling. Which of the following is the most likely cause of this patient&#8217;s clinical presentation?",
      "choices": [
        {
          "id": 1,
          "text": "Systemic release of histamine and bradykinin"
        },
        {
          "id": 2,
          "text": "Bacteremia due to a Gram-negative diplococci"
        },
        {
          "id": 3,
          "text": "C1 esterase inhibitor deficiency"
        },
        {
          "id": 4,
          "text": "Paraneoplastic serotonin secretion"
        },
        {
          "id": 5,
          "text": "Bacterial histidine decarboxylase conversion of histidine to histamine &#160;"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient presents with wheezing, hypotension, airway edema, and a diffuse macular rash consistent with <strong>anaphylactic shock</strong>. This subtype of distributive shock, or &#8220;warm shock,&#8221; is due to systemic release of <strong>histamine&#160;</strong>and <strong>bradykinin&#160;</strong>in response to an allergen. &#160; <br><br>Anaphylaxis is the most extreme physiologic response to an allergen. Common triggers include peanut allergies or bee stings. It is classified as a <strong>type I hypersensitivity reaction</strong>, wherein the antigen cross-links performed IgE on presensitized mast cells, resulting in immediate degranulation of histamine and bradykinin. These mediators further trigger an inflammatory response that results in <strong>massive vasodilation and soft tissue edema</strong>. Edema of the airway causes bronchoconstriction, wheezing, and hypoxemic respiratory failure. Vasodilation subsequently <strong>decreases systemic vascular resistance</strong>, <strong>venous return</strong>, and <strong>pulmonary capillary wedge pressure</strong>. These changes can result in inadequate tissue perfusion. In response, the body compensates by increasing heart rate and cardiac output. &#160; <br><br>Emergent treatment of anaphylaxis involves <strong>intramuscular epinephrine</strong>, which reverses these pathologic effects via vasoconstriction (by stimulating alpha-1 receptors) and bronchodilation (by stimulating beta-2 receptors). Additional therapy includes systemic corticosteroids and antihistamines. &#160;<br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/XtbcEe5cSbyJFTp6zx0P2I_8RDCmU_70/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Systemic release of histamine and bradykinin:</strong><br><span style='opacity:0.9'><strong>Correct:</strong> See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Bacteremia due to a Gram-negative diplococci:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Infection by the Gram-negative diplococci Neisseria meningitis can lead to septic shock. However, septic shock would not typically present with diffuse wheezing or severe lip and tongue swelling.</span></div><div style='margin-bottom: 12px;'><strong>❌ C1 esterase inhibitor deficiency:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Hereditary angioedema is caused by a deficiency in C1 esterase and manifests with tongue, lip, and pharyngeal swelling that can progress to hypoxemic failure. Unlike anaphylaxis, this disease does not typically present with a diffuse macular rash.</span></div><div style='margin-bottom: 12px;'><strong>❌ Paraneoplastic serotonin secretion:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Carcinoid syndrome is due to release of serotonin and vasoactive peptides from a carcinoid tumor. Symptoms include diarrhea, flushing, and wheezing. However, carcinoid syndrome is overall a rare condition and would not account for the patient&#8217;s lip and tongue swelling.</span></div><div style='margin-bottom: 12px;'><strong>❌ Bacterial histidine decarboxylase conversion of histidine to histamine &#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Scombroid toxicity is a common mimicker of anaphylaxis. It is caused by consumption of spoiled dark-meat fish such as tuna, mahi-mahi, mackerel, and bonito. This patient has no history of ingestion of these fish products, making this diagnosis unlikely.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 32-year-old male is brought to the emergency department after being involved in a high speed motor vehicle collision. Per paramedics, the patient was the restrained driver and was rear-ended by another vehicle traveling approximately 60 miles per hour. The patient endorses difficulty moving his arms and legs, and endorses pain to the back of his neck. He is otherwise healthy and does not take any medications. Temperature is 37.0&#176;C (98.6&#176;F), pulse is 42/min, respirations are 17/min, blood pressure is 80/60 mmHg, and O<sub>2</sub> saturation is 97% on room air. On physical exam, the patient has a large bruise over the anterior chest wall and abdomen. Cardiopulmonary exam is otherwise unremarkable. He is unable to move his arms or legs to command and has absent reflexes below the C6 level. Which of the following best describes the underlying pathophysiology resulting in this patient&#8217;s clinical presentation?",
      "choices": [
        {
          "id": 1,
          "text": "Impaired sympathetic outflow"
        },
        {
          "id": 2,
          "text": "Inadequate perfusion due to loss of intravascular volume"
        },
        {
          "id": 3,
          "text": "Compression of mediastinal structures and impaired cardiac outflow"
        },
        {
          "id": 4,
          "text": "Impaired parasympathetic outflow"
        },
        {
          "id": 5,
          "text": "Blunt cardiac injury and excess fluid between the heart and pericardium"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This trauma patient presents after a high speed motor vehicle collision with absent reflexes and paralysis below the C6 level. His vitals demonstrate signs of autonomic dysfunction consistent with <strong>neurogenic shock</strong>, which is due to <strong>impaired sympathetic outflow</strong>. &#160; <br><br>Neurogenic shock is a type of distributive or &#8220;warm&#8221; shock characterized by inadequate tissue perfusion in the setting of autonomic instability from injury to the central nervous system. Neurogenic shock is most commonly caused by cervical or thoracic spine injuries, but it can also be caused by intracranial hemorrhage, traumatic brain injuries, or inflammatory neuropathies. Most commonly, damage to axons and neural membranes in the intermediolateral nucleus, lateral grey matter, and anterior roots leads to <strong>disrupted sympathetic tone</strong> and subsequent <strong>unopposed parasympathetic outflow</strong>. Unopposed parasympathetic tone can cause systemic vasodilation, bradycardia, and bradypnea. &#160; <br><br>Ultimately, this manifests with a <strong>decreased systemic vascular resistance</strong>, <strong>decreased pulmonary capillary wedge pressure</strong>, and <strong>decreased cardiac output</strong>. Hence, it is the only type of shock that <strong>does not appropriately respond with reflex tachycardia to hypotension</strong>. Patients typically present with flushing, warm extremities, autonomic instability, and decreased or <strong>absent reflexes below the level of the injury</strong>.<br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/QGqANrd0TdyQkhCdpHxhmR6DR_urr93E/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Impaired sympathetic outflow:</strong><br><span style='opacity:0.9'><strong>Correct:</strong> See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Inadequate perfusion due to loss of intravascular volume:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Hypovolemic shock should always be considered in an unstable trauma patient. While intra-abdominal injury and subsequent hemoperitoneum is possible, it is unlikely given his relative bradycardia. Hypovolemic shock presents with compensatory reflex tachycardia due to ongoing volume losses.</span></div><div style='margin-bottom: 12px;'><strong>❌ Compression of mediastinal structures and impaired cardiac outflow:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Tension pneumothorax presents with absent unilateral breath sounds, tracheal deviation, and jugular venous distension. It is unlikely that this patient, who has a normal cardiopulmonary exam and oxygen saturation of 97% on room air, has a tension pneumothorax.</span></div><div style='margin-bottom: 12px;'><strong>❌ Impaired parasympathetic outflow:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Impaired parasympathetic outflow would result in hypertension, tachycardia, and tachypnea. &#160;Sympathetic, not parasympathetic, outflow is disrupted in neurogenic shock. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Blunt cardiac injury and excess fluid between the heart and pericardium:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Pericardial tamponade, a form of obstructive shock, presents with Beck triad: muffled heart tones, jugular venous distension, and low blood pressure. In contrast, this patient's cardiopulmonary exam is normal.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 47-year-old female presents to the emergency department with altered mental status. Per emergency medical services, she was found at home surrounded by several empty bottles of vodka. Past medical history is notable for alcohol use disorder, cirrhosis, and heart failure. Temperature is 35.5&#176;C (96.0&#176;F), pulse is 141/min, respirations are 36/min, blood pressure is 75/50 mmHg, and O2 saturation is 96% on room air. On physical exam, she is unresponsive and dried blood is observed at the mouth and nares. The patient is jaundiced with clammy and cool extremities. Cardiopulmonary exam is otherwise unremarkable. Electrocardiogram demonstrates sinus tachycardia. Which of the following best describes the physiological parameters of this patient&#8217;s clinical condition?",
      "choices": [
        {
          "id": 1,
          "text": ""
        },
        {
          "id": 2,
          "text": ""
        },
        {
          "id": 3,
          "text": ""
        },
        {
          "id": 4,
          "text": ""
        },
        {
          "id": 5,
          "text": ""
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient with a history of alcohol use disorder and cirrhosis presents with altered mental status and signs of hemodynamic instability. On physical exam, the patient has cold and clammy extremities with dried blood at the mouth and nares, an ominous sign for ongoing <strong>hemorrhagic shock due to variceal bleeding</strong>. Of the physiologic parameters listed, decreased PCWP, decreased CO, increased SVR, and decreased SvO2 are consistent with <strong>hypovolemic shock</strong>. &#160; <br><br>Hypovolemic shock refers to impaired end-organ perfusion due to decreased intravascular volume. There are two types of hypovolemic shock: <strong>hemorrhagic and nonhemorrhagic</strong>. Hemorrhagic shock occurs due to blood loss from gastrointestinal bleeding, trauma, postpartum complications, surgical complications, or aneurysmal rupture. Non-hemorrhagic shock occurs due to fluid losses including massive diarrhea, vomiting, or severe burns. &#160; <br><br>In either case, <strong>decreased circulating intravascular volume</strong> leads to decreased venous return, decreased cardiac output, and decreased pulmonary capillary wedge pressure (which is reflective of left atrial pressure). As a compensatory mechanism, heart rate increases and the peripheral vasculature vasoconstricts to shunt blood towards vital organs. Due to this shift in vascular flow, patients develop <strong>cold peripheral extremities</strong>, <strong>pallor</strong>, and <strong>clammy skin</strong>. Additionally, decreased intravascular volume and decreased oxygen carrying capacity decreases the mixed venous oxygen saturation. Treatment includes providing volume replacement: blood in the case of hemorrhage shock and intravenous fluids in the setting of non-hemorrhagic shock. &#160;<br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/OyaEmtt1Sjy765wK1gT9kMHTR_WZOmJA/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ :</strong><br><span style='opacity:0.9'><strong>Correct:</strong> See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ :</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>These findings are consistent with cardiogenic shock, which is also a type of &#8220;cold shock&#8221; that presents with cool and clammy extremities. Unlike hypovolemic shock, cardiogenic shock demonstrates an increased pulmonary capillary wedge pressure due to impaired cardiac contractility. Although this patient has a history of heart failure, the physical exam fails to demonstrate evidence of new murmur or pulmonary edema, making cardiogenic shock less likely.</span></div><div style='margin-bottom: 12px;'><strong>❌ :</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> These physiologic parameters reflect shock that has been treated with intravenous fluids, blood products, or inotropic medications. This patient has not yet received any treatment.</span></div><div style='margin-bottom: 12px;'><strong>❌ :</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Distributive shock refers to shock from anaphylaxis or sepsis. Unlike hypovolemic shock, distributive shock is a type of &#8220;warm shock&#8221; (e.g. warm extremities) and presents with a large decrease in systemic vascular resistance due to release of inflammatory mediators.</span></div><div style='margin-bottom: 12px;'><strong>❌ :</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Neurogenic shock falls under the category of &#8220;warm shock&#8221; and presents clinically after severe head or spinal cord trauma or intracerebral hemorrhage. Autonomic instability ensues, resulting in decreased pulmonary capillary wedge pressure, cardiac output, and systemic vascular resistance.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 78-year-old female presents to the emergency department with altered mental status. She was found down by her neighbors, who immediately called EMS. Medical history is notable for multiple myeloma, for which she is currently undergoing treatment. Temperature is 38.9&#176;C (102&#176;F), pulse is 137/min, respirations are 26/min, blood pressure is 87/60 mmHg, and O<sub>2</sub> saturation is 89% on room air. Physical exam reveals a cachectic, ill-appearing woman who is moaning and unable to provide further history. She has bilateral costovertebral angle tenderness to palpation as well as warm and perfused peripheral extremities. Subsequent blood cultures grow gram-negative rods. Which of the following is the most likely trigger of this patient&#8217;s clinical presentation?",
      "choices": [
        {
          "id": 1,
          "text": "Lipid A"
        },
        {
          "id": 2,
          "text": "Histamine and bradykinin"
        },
        {
          "id": 3,
          "text": "Mutation in factor V"
        },
        {
          "id": 4,
          "text": "Thromboplastin"
        },
        {
          "id": 5,
          "text": "Streptolysin O"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient presents with altered mental status, fever, hypotension, and growth of a <strong>g</strong><strong>ram-negative rod</strong> on blood culture. This clinical presentation is consistent with <strong>septic shock</strong> in the setting of pyelonephritis. Of the triggers listed above, <strong>lipid A</strong>, a component of gram-negative bacteria, is responsible for the systemic inflammatory response mediating sepsis. &#160; <br><br>Lipid A is a <strong>heat-stable endotoxin</strong> and component of the lipopolysaccharide cell wall in gram-negative bacteria. When gram-negative bacteria are lysed by the immune system, lipid A is released into the bloodstream, inducing macrophages to release <strong>TNF</strong>, <strong>IL-1</strong>, and<strong>&#160;IL-6</strong>. <span>These inflammatory cytokines activate and injure the vascular endothelium, leading to&#160;</span><span><strong>nitric oxide</strong></span><span>&#160;release and systemic vasodilation. They also promote&#160;</span><strong><span>tissue factor&#160;</span><span>(thromboplastin)</span></strong><span>&#160;expression, triggering the extrinsic coagulation cascade and potentially resulting in&#160;</span><span>disseminated</span><span>&#160;intravascular coagulation.</span>&#160; <br><br>Clinically, septic shock manifests with <strong>decreased systemic vascular resistance</strong>, <strong>decreased venous return</strong>, and <strong>decreased pulmonary capillary wedge pressure</strong>. The heart compensates by <strong>increasing cardiac output</strong>, producing a high flow state wherein tissues cannot properly extract circulating oxygen. This results in <strong>increased anaerobic metabolism</strong>, <strong>lactic acidosis</strong>, and <strong>increased mixed venous oxygen saturation</strong>. &#160; <br><br>If untreated, septic shock portends a high mortality rate due to the body&#8217;s inability to perfuse vital organs. Septic shock can result in multi-organ failure, acute respiratory distress syndrome, and thrombosis. Treatment involves fluid resuscitation, broad spectrum antibiotics, and vasopressors for hemodynamic support. &#160;<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/KvfqjK2OQwi2VAyJ2LGnbznfRd2uwPYj/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Lipid A:</strong><br><span style='opacity:0.9'><strong>Correct:</strong> See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Histamine and bradykinin:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> The primary mediators of anaphylactic shock, which is a subtype of &#8220;warm&#8221; or distributive shock, are histamine and bradykinin. Triggers for anaphylactic shock include bee stings or other allergens such as peanuts. In contrast, this patient has fever, bilateral costovertebral tenderness, and a positive blood culture, which raises more concerns for septic shock secondary to a urinary tract infection.</span></div><div style='margin-bottom: 12px;'><strong>❌ Mutation in factor V:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Factor V Leiden is a hereditary clotting disorder that promotes the formation of deep vein thrombosis and pulmonary embolism, which can lead to obstructive shock. Although this patient is at risk for venous thromboembolism given the history of malignancy, this clinical presentation is more consistent with septic shock.</span></div><div style='margin-bottom: 12px;'><strong>❌ Thromboplastin:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Tissue thromboplastin is commonly activated in the setting of severe sepsis and can lead to disseminated intravascular coagulation (DIC). While this patient has features of septic shock, she does not display features of DIC, such as oozing from IV sites or ecchymosis.</span></div><div style='margin-bottom: 12px;'><strong>❌ Streptolysin O:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Streptolysin O is a protein produced by Streptococcus pyogenes, a gram-positive coccus. This protein degrades cell membranes and lyses red blood cells RBCs. While Streptococcus pyogenes can induce septic shock, this exotoxin is not implicated in its pathogenesis.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 66-year-old man comes to the office due to ankle swelling and abdominal discomfort for the past three weeks. He also has shortness of breath and wheezing on exertion, but he denies orthopnea or paroxysmal nocturnal dyspnea. Patient history is significant for a 50 pack-year smoking history, and he drinks approximately 7-8 units of alcohol per week. His temperature is 37.2&#176;C (98.9&#176; F), pulse is 75/min, respirations are 18/min, and blood pressure is 142/82 mm Hg. Physical examination shows 2+ pitting edema of the lower extremities, tenderness of the right upper quadrant, and prominent jugular veins. Cardiac examination shows a loud pulmonic component of S2 (P2) on auscultation. Which of the following is the most likely etiology of this patient's symptoms? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Hypertension"
        },
        {
          "id": 2,
          "text": "Chronic alcohol use"
        },
        {
          "id": 3,
          "text": "Cor pulmonale"
        },
        {
          "id": 4,
          "text": "Hypertrophic obstructive cardiomyopathy"
        },
        {
          "id": 5,
          "text": "Tuberculosis&#160;&#160;&#160;"
        },
        {
          "id": 6,
          "text": "Mitral insufficiency"
        }
      ],
      "correct_choice_id": 3,
      "solution": "This patient with a significant smoking history is presenting with <strong>peripheral edema</strong>, <strong>hepatic congestion</strong>, <strong>jugular venous distension</strong>, as well as a<strong>&#160;loud P2</strong> on auscultation. These characteristics, in the absence of features of left sided heart failure (e.g., orthopnea, paroxysmal nocturnal dyspnea) all favor the diagnosis of cor pulmonale. <strong>Cor pulmonale</strong> refers to <strong>isolated right heart failure (RHF)</strong> secondary to a pulmonary condition. For example, this patient most likely has chronic obstructive pulmonary disease (COPD) due to chronic smoking, which is contributing to his dyspnea on exertion. COPD causes <strong>hypoxia</strong>, leading to <strong>vasoconstriction&#160;</strong>in the pulmonary vasculature. This elevation in pulmonary arterial pressure causes a backup of pressure into the <strong>right&#160;</strong>ventricle that eventually leads to <strong>right ventricular hypertrophy</strong>. &#160;The loud P2 heard on cardiac auscultation reflects the increased closing pressure of the valve against pulmonary hypertension secondary to lung disease. As the condition progresses, it can lead to isolated RHF. It is important to note that the most common cause of RHF is <strong>left heart failure (LHF)</strong>. &#160; &#160;Since the right side of the heart cannot overcome the pressure in the pulmonary circulation, backward pressure leads to<strong>&#160;jugular venous distention</strong>, <strong>increased portal blood pressure</strong>, and <strong>peripheral edema</strong>. Increased pressure in the portal system presents with <strong>hepatosplenomegaly</strong>, <strong>hepatic pulsation</strong>, <strong>ascites&#160;</strong>and, in severe cases, <strong>cardiac cirrhosis</strong> (i.e., liver cirrhosis due to cardiac causes). On gross morphology, the congested liver is called a <strong>nutmeg liver&#160;</strong>due to congested centrilobular areas surrounded by paler, non-congested parenchyma. &#160;<br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/4q0a6nNNQ0Cv-C9nDHLDH5B6QR_aSGhJ/_.jpg\"></div><br><br>It is important to distinguish RHF and LHF based on the causes, history, clinical examination, and diagnostic investigations: &#160; <br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/Hiu5_Kj5RzWngbB4-5VlxcswT3K2o1Sz/_.png\"></div><br><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Hypertension:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Prolonged hypertension can result in left ventricular concentric hypertrophy and diastolic dysfunction (the heart can not fill properly) due to reduced compliance. This can eventually lead to left-sided heart failure. Symptoms of left-sided heart failure include dyspnea, orthopnea, and paroxysmal nocturnal dyspnea due to pulmonary edema. This patient has clinical features of right-sided heart failure. Although this patient has dyspnea, this is most likely due to a primary lung condition, such as COPD, secondary to smoking. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Chronic alcohol use:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Chronic alcohol use is a cause of dilated cardiomyopathy. This results in eccentric hypertrophy of the heart and systolic dysfunction (the heart can not pump blood out), which leads to left-sided heart failure. This diagnosis is unlikely as the patient is presenting with right-sided heart failure. In addition, he is drinking a moderate level, and a S3 (sign of volume overload) would be expected as opposed to a loud P2 on auscultation.</span></div><div style='margin-bottom: 12px;'><strong>✅ Cor pulmonale:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Hypertrophic obstructive cardiomyopathy:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Hypertrophic obstructive cardiomyopathy (HOCM) is an autosomal dominant condition most commonly caused by a mutation in genes which encode sarcomeric proteins. This mutation leads to asymmetric septal hypertrophy and systolic anterior motion of the mitral valve which results in outlet obstruction. Presentation is variable and may include dyspnea on exertion, fatigue, atypical or anginal chest pain, palpitations, syncope, sudden cardiac death. This condition usually affects younger athletes.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Tuberculosis&#160;&#160;&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Tuberculosis is a cause of constrictive pericarditis, which can eventually lead to diastolic dysfunction and right heart failure. Constrictive pericarditis can present with signs of right heart side failure as seen in this patient. However, other signs of tuberculosis would also be expected (e.g., cough, hemoptysis, fever, and night sweats). &#160;&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Mitral insufficiency:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Mitral insufficiency can cause left sided failure. However, mitral insufficiency (i.e. regurgitation) will present with a holosystolic murmur best heard at the apex, not a loud P2. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 74-year-old woman presents to her primary care physician for evaluation of shortness of breath. Over the past several weeks, the patient has been using three to four pillows to prop herself up to sleep at night. Past medical history includes hypertension, diabetes, hyperlipidemia, and myocardial infarction with stent placement. Temperature is 37.0&#176;C (98.6&#176;F), pulse is 78/min, respirations are 18/min, blood pressure is 148/82 mmHg, and O2 saturation is 97% on room air. Physical examination demonstrates an additional low frequency heart sound heard just after S2. Which of the following best describes the underlying pathophysiology of this cardiac finding? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Increased ventricular filling pressure"
        },
        {
          "id": 2,
          "text": "Ventricular non-compliance&#160;"
        },
        {
          "id": 3,
          "text": "Untreated Streptococcal throat infection"
        },
        {
          "id": 4,
          "text": "Age-related calcification of the aortic valve"
        },
        {
          "id": 5,
          "text": "Ventricular septal defect&#160;"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient presents with cardiac auscultatory findings characteristic of an <strong>S3 or ventricular gallop</strong>. The finding is most commonly associated with <strong>heart failure</strong> and<strong>&#160;increased ventricular filling pressures. &#160;</strong>&#160;<br><br>The third heart sound (S3) is clinically characterized as a low-frequency, brief vibration occurring in early diastole at the end of the rapid diastolic filling period of the right or left ventricle. In other words, this sound is heard immediately after the normal two \"lub-dub\" heart sounds (S1 and S2). The sound itself occurs as blood oscillates back and forth between the walls of dilated, compliant ventricles and is observed in patients with heart failure. This heart sound is best heard over the cardiac apex with the patient lying in the left lateral decubitus position. &#160; <br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Increased ventricular filling pressure:</strong><br><span style='opacity:0.9'><strong>Correct: </strong>See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Ventricular non-compliance&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>The S4 gallop, characterized by an extra heart sound heard in late diastole, occurs just after atrial contraction and immediately before the systolic S1 heart sound. This heart sound is reflective of an abnormally stiff or hypertrophic ventricle. In contrast, this patient&#8217;s extra heart sound is characteristic of an S3 gallop.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Untreated Streptococcal throat infection:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Rheumatic heart disease typically results in the development of mitral stenosis. This valvular pathology is characterized by an opening snap followed by a diastolic murmur. In contrast, this patient&#8217;s extra heart sound is characteristic of an S3 gallop.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Age-related calcification of the aortic valve:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Aortic stenosis is most commonly due to age-related calcification of the aortic valve and is characterized by a crescendo-decrescendo systolic ejection murmur and soft S2 heart sound. In contrast, this patient&#8217;s extra heart sound is characteristic of an S3 gallop.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Ventricular septal defect&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Ventricular septal defects are characterized by holosystolic, harsh-sounding murmurs. In contrast, this patient&#8217;s extra heart sound is characteristic of an S3 gallop.&#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 71-year-old man presents to the emergency department due to shortness of breath with exertion and difficulty sleeping. The patient has experienced progressive shortness of breath over the past several weeks to the point where he can no longer walk to the bathroom without becoming winded. He has woken up multiple times per night with shortness of breath and has been propping himself up with several pillows to sleep. Past medical history includes hypertension, hyperlipidemia, diabetes, a 25-pack-year smoking history, and heart failure (ejection fraction 14%). He is adherent to prescribed medications, including furosemide. Temperature is 36.1&#176;C (97.0&#176;F), pulse is 101/min, respirations are 24/min, blood pressure is 101/82 mmHg, and O2 saturation is 90% on room air. Physical examination demonstrates an additional heart sound heard just after S2, jugular venous distension, diffuse rales on auscultation of the lungs, and pitting edema of the lower extremities. Which of the following findings is most likely present in this patient? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Increased levels of angiotensin II"
        },
        {
          "id": 2,
          "text": "Increased renal perfusion"
        },
        {
          "id": 3,
          "text": "Cor pulmonale"
        },
        {
          "id": 4,
          "text": "Increased stroke volume&#160;"
        },
        {
          "id": 5,
          "text": "Decreased brain and atrial natriuretic peptide levels"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient presents with features of <strong>left ventricular dysfunction</strong> (e.g., dyspnea, orthopnea, pulmonary edema), <strong>right ventricular failure</strong> (e.g., jugular venous distention, lower extremity edema), and<strong>&#160;heart failure with reduced ejection fraction. &#160;</strong>&#160;<br><br>In patients with decompensated heart failure, neuroendocrine mechanisms contribute to a vicious cycle in an attempt to restore hemodynamics. Diminished cardiac output fails to perfuse vital organs like the kidneys, prompting <strong>activation of the renin-angiotensin-aldosterone system</strong> (RAAS). Activation of RAAS promotes <strong>increased levels of angiotensin II,</strong> a potent vasoconstrictor, and <strong>aldosterone</strong>, which increases sodium and water retention. Together, these two sequelae of the RAAS system also lead to increased afterload. Concurrently, the diminished cardiac output manifests with activation of the <strong>sympathetic nervous system</strong>, which further increases arteriolar tone and afterload. &#160;<br><br>Over time, the compensatory mechanisms of the heart (e.g. secretion of the diuretic and vasodilatory peptides BNP/ANP) fail to compensate for this overactivation of the sympathetic nervous and RAAS systems, thus lending towards a vicious cycle of increasing afterload, strain on the left ventricle, and decompensated heart failure.<br><br>&#160;<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/zdlP_5LKRzOp2Y7N6yod2Nb4TUmnSaLe/_.png\"></div><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Increased levels of angiotensin II:</strong><br><span style='opacity:0.9'><strong>Correct:&#160;</strong>See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Increased renal perfusion:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Decreased, not increased, renal perfusion is observed in patients with decompensated heart failure. Decreased renal perfusion results in increased activation of the renin-angiotensin-aldosterone system, which further worsens the symptoms of heart failure. &#160; &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Cor pulmonale:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Cor pulmonale refers to isolated right heart failure. In contrast, this patient presents with clinical findings of left ventricular dysfunction.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Increased stroke volume&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Stroke volume may slightly increase in early heart failure as a compensatory mechanism. However, later in the disease, stroke volume becomes profoundly diminished.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Decreased brain and atrial natriuretic peptide levels:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Both brain natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) are protein molecules secreted by the atria and ventricles in response to stretch. These molecules serve to counteract the negative effects of heart failure by promoting diuresis and vasodilation. Both of these peptides are elevated in patients with decompensated heart failure.&#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 57-year-old man presents to the emergency department due to increasing shortness of breath over the past several weeks. The patient can no longer climb a flight of stairs or walk one city block without becoming short of breath. Past medical history includes diabetes and hypertension. The patient has not seen a physician in years and is currently not on any medications. He smokes one pack of cigarettes per day. Temperature is 36.1&#176;C (97.0&#176;F), pulse is 78/min, respirations are 22/min, blood pressure is 201/97 mmHg, and O2 saturation is 93% on room air. Physical examination demonstrates bibasilar rales and a palpable S4 heart sound. Bedside point of care ultrasound demonstrates left ventricular hypertrophy. Which of the following best describes the likely physiologic parameters regarding this patient&#8217;s left ventricular cardiac function?<br><br>",
      "choices": [
        {
          "id": 1,
          "text": "&#160;Ejection fraction (EF)&#160;&#160;End diastolic volume (EDV)&#160;&#160;Compliance&#160;&#160;Normal&#160;&#160;Normal&#160;&#160;&#8595;&#160;"
        },
        {
          "id": 2,
          "text": "&#160;Ejection fraction (EF)&#160;&#160;End diastolic volume (EDV)&#160;&#160;Compliance&#160;&#160;&#8595;&#160;&#160;&#8593;&#160;&#8593;"
        },
        {
          "id": 3,
          "text": "&#160;Ejection fraction (EF)&#160;&#160;End diastolic volume (EDV)&#160;&#160;Compliance&#160;&#160;Normal&#160;&#160;&#8593;&#8593;&#160;"
        },
        {
          "id": 4,
          "text": "&#160;Ejection fraction (EF)&#160;&#160;End diastolic volume (EDV)&#160;&#160;Compliance&#160;&#160;Normal&#160;&#160;Normal&#160;&#160;Normal&#160;"
        },
        {
          "id": 5,
          "text": "&#160;Ejection fraction (EF)&#160;&#160;End diastolic volume (EDV)&#160;&#160;Compliance&#160;&#8595;&#160;&#8593;&#160;Normal&#160;"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient with long-standing, untreated hypertension presents with clinical features of heart failure. Specifically, the presence of an S4 gallop and evidence of left ventricular hypertrophy on ultrasound suggest left ventricular diastolic dysfunction. &#160;<br><br><strong>Diastolic heart failure&#160;</strong>is most commonly due to <strong>cardiac hypertrophy</strong> from long-standing, <strong>untreated hypertension</strong>. Diastolic heart failure presents with the same clinical features as systolic heart failure. Echocardiographic findings generally demonstrate a <strong>preserved&#160;</strong>EF and a <strong>normal&#160;</strong>EDV. Patients with diastolic heart failure will also have <strong>decreased compliance&#160;</strong>(increased end diastolic pressure) due to stiff ventricular walls. Other etiologies of diastolic heart failure include infiltrative diseases, such as amyloidosis, sarcoidosis, and post-radiation fibrosis. &#160; &#160;<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/wcdS_hxVRTusmco04Ilh3SIHSQ_q3xGF/_.png\"></div><br>In contrast, <strong>systolic heart failure</strong> is most commonly due to <strong>ischemia&#160;</strong>or <strong>myocardial infarction</strong>, which causes decreased cardiac contractility that leads to systolic dysfunction. Other causes of systolic heart failure include etiologies of dilated cardiomyopathy, such as chronic alcohol use, coxsackie B virus infection, chronic cocaine use, and Chagas disease. The inability of the heart to effectively pump blood forward through the circulation results in clinical features of left-sided heart failure, such as pulmonary edema (e.g., <strong>bibasilar crackles, paroxysmal nocturnal dyspnea</strong>) and an <strong>S3 heart sound&#160;</strong>(ventricular gallop). Systolic heart failure often progresses to right-sided heart failure, resulting in <strong>jugular venous distention</strong> (JVD), <strong>pitting edema</strong>, and<strong>&#160;hepatic congestion</strong>. Echocardiography in systolic heart failure typically shows an <strong>increased end diastolic volume</strong> (EDV), <strong>decreased contractility</strong> (or wall motion abnormalities), and <strong>reduced ejection fraction&#160;</strong>(EF). &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ &#160;Ejection fraction (EF)&#160;&#160;End diastolic volume (EDV)&#160;&#160;Compliance&#160;&#160;Normal&#160;&#160;Normal&#160;&#160;&#8595;&#160;:</strong><br><span style='opacity:0.9'><strong>Correct:&#160;</strong>See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ &#160;Ejection fraction (EF)&#160;&#160;End diastolic volume (EDV)&#160;&#160;Compliance&#160;&#160;&#8595;&#160;&#160;&#8593;&#160;&#8593;:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>These findings are indicative of systolic heart failure, not diastolic heart failure.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ &#160;Ejection fraction (EF)&#160;&#160;End diastolic volume (EDV)&#160;&#160;Compliance&#160;&#160;Normal&#160;&#160;&#8593;&#8593;&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> These findings are indicative of a recovered ejection fraction or impending heart failure (compensatory).&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ &#160;Ejection fraction (EF)&#160;&#160;End diastolic volume (EDV)&#160;&#160;Compliance&#160;&#160;Normal&#160;&#160;Normal&#160;&#160;Normal&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>These findings describe healthy cardiac function without evidence of underlying pathology. This patient has multiple clinical features that suggest underlying diastolic heart failure.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ &#160;Ejection fraction (EF)&#160;&#160;End diastolic volume (EDV)&#160;&#160;Compliance&#160;&#8595;&#160;&#8593;&#160;Normal&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>These findings may be present in cases of neurogenic shock, wherein decreased sympathetic tone manifests with a decrease in ejection fraction and subsequent increase in EDV.&#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 52-year-old man comes to the emergency department with shortness of breath, which began four hours ago. The patient also has swelling of the bilateral lower extremities. Past medical history is notable for hypertension, type II diabetes mellitus, and congestive heart failure. At arrival, his temperature is 37.7&#176;C (99.9&#176;F), blood pressure is 145/87 mmHg, pulse is 92/min, and respiratory rate is 20/min. Physical examination reveals bibasilar inspiratory crackles and pitting edema in the lower extremities. Imaging is ordered and reveals the findings below. Laboratory testing reveals a sodium level of 135 mEq/L and potassium of 5.3 mEq/L. Concurrent administration of the following medications should be avoided in this patient? <br>&#160;<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/pG9gwRS7TQmMm-SE5nndZgt-T7O2hqoV/_.jpg\"></div><br><strong><sup>Image reproduced from Radiopedia</sup></strong>",
      "choices": [
        {
          "id": 1,
          "text": "Triamterene"
        },
        {
          "id": 2,
          "text": "Metformin"
        },
        {
          "id": 3,
          "text": "Furosemide"
        },
        {
          "id": 4,
          "text": "Hydralazine"
        },
        {
          "id": 5,
          "text": "Glyburide"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient has shortness of breath, peripheral edema, and increased lung shadowing on the x-ray in the setting of congestive heart disease. He most likely has pulmonary edema. Laboratory testing reveals hyperkalemia. To avoid exacerbating the electrolyte abnormality or triggering an arrhythmia, patients with hyperkalemia should avoid taking potassium-sparing diuretics.<br><br>Potassium-sparing diuretics are used in the treatment of <strong>hypertension&#160;</strong>and edematous states, such as <strong>pulmonary edema&#160;</strong>and <strong>abdominal ascites</strong>. This is because potassium-sparing diuretics increase sodium and water loss via urine, which helps decrease plasma volume, cardiac output, and extracellular fluid volume. In addition, potassium-sparing diuretics that act as aldosterone receptor antagonists (e.g., spironolactone, eplerenone) are useful in treating conditions associated with <strong>hyperaldosteronism&#160;</strong>(e.g., adrenal adenoma, adrenal hyperplasia).<br><br>Finally, spironolactone and amiloride can bind to androgen receptors and prevent testosterone from binding. These medications help blunt the effects of testosterone in the body and can be used to manage conditions such as <strong>polycystic ovarian syndrome</strong> (PCOS). Of note, spironolactone has stronger antiandrogenic properties and is used more commonly than amiloride to treat PCOS.<br><br>Side effects on these medications include <strong>hyperkalemia&#160;</strong>(due to reduced potassium excretion) and <strong>metabolic acidosis</strong> (due to reduced potassium excretion). In addition, spironolactone can cause <strong>gynecomastia&#160;</strong>as a side effect. <br>&#160;<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/FeEYK-VdRz_jgLJinFKHo15uQ4WItGdX/_.png\"></div><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Triamterene:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Metformin:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: This patient has pulmonary and peripheral edema, likely due to congestive heart failure exacerbation. Laboratory testing reveals hyperkalemia and medications that increase serum potassium levels should be used with caution, as they may exacerbate hyperkalemia and cause arrhythmias. However, metformin does not typically increase serum potassium levels. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Furosemide:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Furosemide is a loop diuretic that causes hypokalemia as a side effect. As a result, it can be administered safely to this patient, who has hyperkalemia. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Hydralazine:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Hydralazine is an antihypertensive that causes vasodilation. Side effects include headache, reflex tachycardia, and lupus-like syndrome. However, it does not exacerbate hyperkalemia. Hence, hydralazine can be safely administered to this patient. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Glyburide:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Glyburide is a medication that increases endogenous insulin release. Side effects include disulfiram-like reactions, hypoglycemia, and weight gain. However, glyburide would not typically cause hyperkalemia and would not exacerbate this patient&#8217;s electrolyte abnormality. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 67-year-old man is brought to the emergency department with shortness of breath and palpitations for 2 hours. Past medical history is significant for congestive heart failure, nonischemic cardiomyopathy, and hypertension. Current medications include furosemide, metoprolol, lisinopril, and digoxin. The patient&#8217;s ejection fraction on transthoracic echocardiography a month ago was 40%. Temperature is 37.0&#176;C (98.6&#176;F), pulse is 125/min, respirations are 20/min, and blood pressure is 155/95 mmHg. Physical examination is unremarkable. ECG shows absent P waves with an irregularly irregular rhythm and nonspecific T wave changes. The patient is started on apixaban and amiodarone. His symptoms improved during the hospital stay, and he was discharged home on day three, with these new medications added to his regimen. He returns to the emergency department a week later with generalized fatigue, nausea, non-bloody vomiting, and nonspecific abdominal pain. Which of the following is the most likely cause of this patient&#8217;s symptoms? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Erosive gastritis"
        },
        {
          "id": 2,
          "text": "Pancreatitis"
        },
        {
          "id": 3,
          "text": "Drug interaction"
        },
        {
          "id": 4,
          "text": "Apixaban toxicity"
        },
        {
          "id": 5,
          "text": "Heart failure exacerbation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "This patient&#8217;s current presentation with <strong>generalized fatigue, nausea, non-bloody vomiting, and nonspecific abdominal pain</strong> suggests <strong>digoxin toxicity</strong>, most likely due to the addition of <strong>amiodarone&#160;</strong>to the patient&#8217;s medication regimen.<br><br><strong>Acute toxicity</strong> can present with <strong>nausea, vomiting, hyperkalemia,&#160;</strong>and <strong>cardiac arrhythmias</strong> (sinus bradycardia, paroxysmal atrial tachycardia with AV block, ventricular tachycardia, and ventricular fibrillation). In contrast, chronic toxicity presents with less profound gastrointestinal symptoms and more significant <strong>neurological&#160;</strong>(e.g., lethargy, fatigue, and confusion) and <strong>visual&#160;</strong>(e.g., changes in color vision and scotomas) symptoms.<br><br><strong>Amiodarone</strong>, verapamil, quinidine, or propafenone (when coadministered with digoxin) can increase the risk of digoxin toxicity by <strong>reducing its renal excretion</strong> (competing for or inhibiting P-glycoprotein) <strong>or by displacement of digoxin from tissue binding sites</strong>. This leads to increased serum levels in a patient who has previously been on a stable digoxin regimen. It is recommended to decrease the dose of digoxin by 20-50% when initiating therapy with any of these drugs.<br><br>Other factors that increase the risk of digoxin toxicity include:<br><br><ul><li><strong>Hypokalemia&#160;</strong>which can increase digoxin binding at the K+-binding site on Na<sup>+</sup>/K<sup>+</sup> ATPase</li><li>Hypomagnesemia (which leads to hypokalemia)</li><li><strong>Renal failure</strong> (decreased digoxin clearance)</li></ul>&#160;<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/_Pk4swInRjqRnlgSmrCon_DkTUarmVpN/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Erosive gastritis:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Erosive gastritis can present with nausea, vomiting, and abdominal pain. This patient's presentation with generalized fatigue in a possible drug interaction makes this unlikely. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Pancreatitis:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Pancreatitis usually presents with nausea, vomiting, and epigastric abdominal pain radiating to the back in predisposing factors (e.g., excessive alcohol use and gallstones). This patient&#8217;s presentation is not typical of pancreatitis. &#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Drug interaction:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Apixaban toxicity:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Apixaban is an anticoagulant, and its toxicity can present with bleeding gums, epistaxis, hematuria, melena, or hematochezia, none of which are seen in this patient. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Heart failure exacerbation:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Heart failure exacerbation usually presents with exertional dyspnea, fatigue, paroxysmal nocturnal dyspnea, orthopnea, cough, early satiety, weight gain, and increasing abdominal girth. It is unlikely to be the cause of this patient&#8217;s presentation. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "<span>A 65-year-old man comes to the emergency department because of progressive difficulty breathing, which has been ongoing for the last 2 days. Past medical history is significant for type II diabetes mellitus, hypertension, hyperlipidemia, ischemic cardiomyopathy, and heart failure with an ejection fraction of 31%. The patient does not take his medications and consumes salty foods. Temperature is 37.1&#176;C (98.9&#176;F), pulse is 87/min, respirations are 20/min, and blood pressure is 144/78 mmHg. Physical examination</span><span>&#160;shows a man with labored breathing and bilateral lower extremity edema. Auscultation of the lungs reveals bilateral crackles. The patient is admitted to the hospital and started on intravenous furosemide. This medication acts on which of the following regions of the nephron?</span>&#160;<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/vadS4Uh5RUa2voC9sF6bDna_TxegDfwR/_.png\"></div><br>",
      "choices": [
        {
          "id": 1,
          "text": "Region A"
        },
        {
          "id": 2,
          "text": "Region B"
        },
        {
          "id": 3,
          "text": "Region C"
        },
        {
          "id": 4,
          "text": "Region D"
        },
        {
          "id": 5,
          "text": "Region E"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/i94j5YDxRkypCmul3xyFZDDdS1uc7BRi/_.png\"></div><br><br>This patient&#8217;s presentation is consistent with acute decompensated heart failure. The mainstay of management involves intravenous diuresis, typically with a loop diuretic such as furosemide. &#160; &#160; &#160; &#160;<br><br>In the<strong>&#160;</strong><strong>thick ascending limb of the loop of Henle</strong>, loop diuretics (e.g., <strong>furosemide</strong>, bumetanide, torsemide) bind and inhibit the<strong>&#160;Na+/K+/2Cl</strong>- symporter. As a result, sodium, potassium, and chloride cannot be reabsorbed into the bloodstream and get excreted out with the urine. Other ions that depend on sodium reabsorption, such as calcium and magnesium, are excreted as well. These changes ultimately lead to<strong>&#160;decreased water reabsorption</strong> in the distal convoluted tubule. &#160; &#160; &#160; &#160;<br><br>Major indications for loop diuretics include <strong>hypertension&#160;</strong>and <strong>edematous states</strong> (e.g., heart failure, ascites, acute pulmonary edema). Moreover, these medications can also be used to correct certain electrolyte imbalances such as <strong>hypercalcemia&#160;</strong>and <strong>hyperkalemia</strong>. Lastly, loop diuretics are also effective in treating acute bromide, fluoride, or iodide <strong>intoxications&#160;</strong>because these substances are also reabsorbed in the thick ascending limb. &#160; <br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/HzVZjsV3QPGMt1pXi5sXjP6kT7yr6fB4/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Region A:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong><strong>&#160;</strong>Acetazolamide works by inhibiting carbonic anhydrase in the proximal tubule, thereby blocking NaHCO3, and water reabsorption and resulting in urinary bicarbonate wasting. It is used to relieve intracranial pressure in idiopathic intracranial hypertension and intraocular pressure in glaucoma. Furosemide, in contrast, acts on a different part of the nephron.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Region B:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> The descending loop of Henle carries fluid from the proximal tubule to the ascending loop of Henle. It allows reabsorption of water into the interstitial fluids to produce concentrated urine. However, loop diuretics such as furosemide act on a different part of the nephron.&#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Region C:</strong><br><span style='opacity:0.9'><strong>Correct:</strong><strong>&#160;</strong>See Main Explanation.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Region D:</strong><br><span style='opacity:0.9'><span><strong>Incorrect:&#160;</strong></span><span>Thiazide diuretics (e.g., hydrochlorothiazide) act on the early distal tubule, where they inhibit Na</span><span>+</span><span>/Cl</span><span>-</span><span>&#160;</span><span>contransporters</span><span>.</span>&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Region E:</strong><br><span style='opacity:0.9'><span><strong>Incorrect:&#160;</strong></span><span>Potassium-sparing diuretics and aldosterone antagonists act on the collecting tubules. Loop diuretics, such as furosemide, do not act here.</span>&#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "<span>A 65-year-old woman presents to the emergency department with severe shortness of breath and orthopnea. Past medical history is significant for long-standing hypertension and myocardial infarction, which occurred 9 months ago. Temperature is 37.1&#176;C (98.9&#176;F), pulse is 87/min, respirations are 20/min and blood pressure&#160;</span><span>is</span><span>&#160;144/</span><span>78 mm</span><span>Hg. Physical examination shows elevated jugular venous pressure and pitting edema in the bilateral lower extremities. Auscultation of the lungs reveals bilateral crackles. The patie</span><span>nt is treated with a medication that results in brisk diuresis and&#160;</span><span>subsequent</span><span>&#160;symptomatic improvement. The patient is sent home on this medication. Three weeks later, laboratory analysis revealed reduced serum calcium and magnesium levels. The diuretic prescribed to this patient&#160;</span><span>predominantly acts</span><span>&#160;on which of the following nephron segments?</span>&#160;",
      "choices": [
        {
          "id": 1,
          "text": "Proximal tubule"
        },
        {
          "id": 2,
          "text": "Descending loop of Henle"
        },
        {
          "id": 3,
          "text": "Thick ascending loop of Henle"
        },
        {
          "id": 4,
          "text": "Distal tubule"
        },
        {
          "id": 5,
          "text": "Cortical collecting duct&#160;"
        }
      ],
      "correct_choice_id": 3,
      "solution": "This patient presents with symptoms of acute decompensated heart failure. The mainstay of management is intravenous diuresis, typically with a<strong>&#160;</strong><strong>loop diuretic</strong> such as furosemide. &#160; &#160; &#160; &#160; <br><br>Loop diuretics act on the ascending limb of the loop of Henle by binding and inhibiting the <strong>Na+/K+/2Cl- symporter</strong>. Inhibition of sodium chloride reabsorption also inhibits the back leak of potassium into the tubule and prevents the generation of a positive intraluminal potential within the ascending loop of Henle. As a result, there is a <strong>decreased electrical gradient for magnesium and calcium reabsorption</strong> and increased loss of magnesium and calcium via urine. Due to these effects, loop diuretics can cause hypomagnesemia and hypocalcemia. &#160; &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Proximal tubule:</strong><br><span style='opacity:0.9'><span><strong>Incorrect: </strong></span><span>Acetazolamide works by inhibiting carbonic anhydrase in the proximal tubule, thereby blocking NaHCO</span><span>3,</span><span>&#160;and water reabsorption and resulting in urinary bicarbonate wasting. Acetazolamide may cause metabolic acidosis, but not hypocalcemia and hypomagnesemia.</span>&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Descending loop of Henle:</strong><br><span style='opacity:0.9'><span><strong>Incorrect: </strong></span><span>The descending loop of Henle is not a common site of action for diuretics.</span>&#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Thick ascending loop of Henle:</strong><br><span style='opacity:0.9'><strong>Correct:</strong>&#160;See Main Explanation.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Distal tubule:</strong><br><span style='opacity:0.9'><span><strong>Incorrect: </strong></span><span>Thiazide diuretics (</span><span>e.g.</span><span>&#160;hydrochlorothiazide) act on the early distal tubule and inhibit NaCl reabsorption. While thiazide diuretics may cause hypomagnesemia, they do not typically cause hypocalcemia.</span>&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Cortical collecting duct&#160;:</strong><br><span style='opacity:0.9'><span><strong>Incorrect: </strong></span><span>Potassium-sparing diuretics and aldosterone antagonists act on collecting duct systems. However, these medications are not typically associated with hypocalcemia or hypomagnesemia.</span>&#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 68-year-old woman is brought to the emergency department because of a two-day history of shortness of breath and confusion. Past medical history is significant for hypertension and heart failure with reduced ejection fraction (last estimated to be 20%). The patient reports infrequent follow-up visits and medication nonadherence. Temperature is 37.0&#176;C (98.6&#176;F), pulse is 112/min, respirations are 22/min, and blood pressure is 73/45 mm Hg. Physical examination shows cool extremities, jugular venous distention, and diffuse crackles in the lungs. Treatment with intravenous agents is started. The agents specifically decrease the rate of cyclic adenosine monophosphate (AMP) degradation via the inhibition of an enzyme. Which of the following is an example of the drug used in managing this patient? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Milrinone"
        },
        {
          "id": 2,
          "text": "Dobutamine"
        },
        {
          "id": 3,
          "text": "Digoxin"
        },
        {
          "id": 4,
          "text": "Lisinopril"
        },
        {
          "id": 5,
          "text": "Dapagliflozin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient&#8217;s presentation with worsening dyspnea, confusion, bibasilar crackles, and JVD is consistent with <strong>cardiogenic shock</strong> secondary to <strong>heart failure with reduced ejection fraction</strong> (HFrEF). An intravenous <strong>milrinone&#160;</strong>(a phosphodiesterase-3 inhibitor) infusion is started in this patient to improve cardiac contractility.<br><br><strong>PDE-3 inhibitors</strong>, such as milrinone and enoximone, <strong>decrease the rate of cyclic adenosine monophosphate (AMP) degradation</strong>. The ensuing increase in cyclic AMP concentration leads to enhanced calcium influx into the cell, a rise in cell calcium concentration, and <strong>increased contractility</strong>. These drugs also cause <strong>systemic arterial and venous dilation</strong>, viral causes of vascular PDE. Milrinone is used as an inotropic agent in <strong>acute heart failure</strong>. It should not be used in chronic heart failure because it increases morbidity and mortality. Side effects include <strong>arrhythmias and hypotension</strong> due to significant vasodilation.<br>&#160; <div><img src=\"https://d16qt3wv6xm098.cloudfront.net/V33I9kK1QV2wN7HGXuCpkllySbaGjOpu/_.png\"></div><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Milrinone:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Dobutamine:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Dobutamine is a highly selective beta-agonist for beta-1 receptors. It is coupled to Gs protein, which stimulates adenylate cyclase. This increases the production of cAMP (rather than decreasing its degradation) in the target cells leading to an increase in calcium influx into the cells and the force of cardiac muscle contraction (positive inotropy and chronotropy). &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Digoxin:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Digoxin acts by direct inhibition of Na<sup>+</sup>/K<sup>+</sup> ATPase, indirectly inhibiting Na<sup>+</sup>/Ca2<sup>+</sup> exchanger, leading to increased calcium in the sarcoplasmic reticulum. This calcium increases cardiac contractility (positive inotropy) when this calcium is released. It does not affect AMP degradation, an effect similar to that of milrinone. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Lisinopril:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: ACE inhibitors (ACEI) such as captopril, enalapril, or lisinopril, inhibit the action of ACE and prevent the formation of angiotensin II and aldosterone and results in an increase in endogenous vasodilators of the kinin family. It is indicated in hypertension, heart failure, and diabetic nephropathy. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Dapagliflozin:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Dapagliflozin is an SGLT2 inhibitor that reduces blood glucose by increasing urinary glucose excretion and is used to reduce the risk of progression of diabetic kidney disease. It is a treatment option for patients with heart failure with reduced ejection fraction with type 2 diabetes mellitus. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 67-year-old man presents to the emergency department with a cough and shortness of breath. He states that these symptoms have been gradually worsening, but recently, he woke up in the middle of the night suddenly feeling short of breath. He sleeps in a recliner because he gets short of breath while lying flat. Past medical history of obesity and hypertension, which is currently not treated. Temperature is 37.2&#176;C (98.9&#176;F), pulse is 100/min, respirations are 14/min, and blood pressure is 187/108 mmHg. Oxygen saturation is 98% in room air. Physical examination shows mild jugular venous distention. Mild bibasilar crackles are noted on chest auscultation. Which of the following substances will be produced in the small pulmonary vessels in response to this patient&#8217;s condition? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Renin"
        },
        {
          "id": 2,
          "text": "Angiotensin I"
        },
        {
          "id": 3,
          "text": "Angiotensin II"
        },
        {
          "id": 4,
          "text": "Aldosterone"
        },
        {
          "id": 5,
          "text": "Prostaglandin E1"
        }
      ],
      "correct_choice_id": 3,
      "solution": "This patient&#8217;s presentation with cough and shortness of breath, jugular venous distension, and bibasilar crackles are suggestive of <strong>decompensated heart failure.&#160;</strong>The decrease in cardiac output leads to renal hypoperfusion and the subsequent activation of the<strong>&#160;renin-angiotensin-aldosterone system (RAAS). &#160; &#160;</strong><br><br>When blood pressure is low, blood flow to the kidneys decreases. The kidneys respond by secreting renin into the bloodstream. Renin is a proteolytic enzyme that breaks down a protein made in the liver called angiotensinogen, and this gives rise to angiotensin I. When angiotensin I reaches the lungs, angiotensin I is converted into <strong>angiotensin II</strong> by an enzyme called <strong>angiotensin-converting enzyme (ACE)&#160;</strong>in the pulmonary vessels. Angiotensin II binds to receptors in vascular smooth muscle and causes them to constrict, which increases the blood pressure. Finally, angiotensin II also stimulates the release of aldosterone by the adrenal glands. Aldosterone increases the reabsorption of sodium in the kidneys, which also increases water reabsorption. This results in increased blood volume, which also increases blood pressure. &#160;<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/cWLeXkfCSu_-fWOhxROvcnwHTAyXaWFW/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Renin:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Renin is secreted by the juxtaglomerular cells in the kidney in response to decreased cardiac output leading to renal hypoperfusion. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Angiotensin I:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Angiotensinogen is converted to angiotensin I in the systemic circulation via the action of renin. &#160;&#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Angiotensin II:</strong><br><span style='opacity:0.9'><strong>Correct: </strong>See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Aldosterone:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Angiotensin II acts on the adrenal glands to stimulate the production and release of aldosterone, which acts on the collecting duct of the nephron to retain sodium and water. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Prostaglandin E1:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Prostaglandins are produced by endothelial cells, macrophages, and mast cells. It acts on the afferent arterioles of the nephron to cause vasodilation. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 73-year-old man with no significant past medical history develops a bowel perforation and subsequently undergoes surgical repair. He develops significant hypotension while under general anesthesia. Intraoperative blood loss is minimal. A large dose of epinephrine is administered, which temporarily raises the patient's blood pressure. Several subsequent doses of epinephrine are administered and cause a much weaker response. Which of the following mechanisms is likely contributing to the decreased effects of this medication? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Increased activity of intracellular arrestin proteins"
        },
        {
          "id": 2,
          "text": "Increased number of extracellular receptors"
        },
        {
          "id": 3,
          "text": "Increased production of secondary messenger molecules"
        },
        {
          "id": 4,
          "text": "Decreased breakdown of the medication"
        },
        {
          "id": 5,
          "text": "Decreased sequestration of extracellular receptors"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<strong>Desensitization and tolerance</strong> are important concepts in pharmacodynamics and refers to a decreased effect of a drug (e.g. alcohol, heroin) or medication over time following subsequent doses. Over time, as an agonist binds to its cellular receptor, it may lose its ability to produce a robust response within cells via secondary messengers. Desensitization (also called tachyphylaxis) generally occurs rapidly and can occur after the first dose of a medication. On the other hand, tolerance occurs always after repeated doses and may take weeks or months. In this patient, he is likely experiencing desensitization (tachyphylaxis) to epinephrine, so repeated doses exert a weaker effect than the original dose.<br><br>Desensitization and tolerance can occur via many mechanisms, with several of the most common mechanisms outlined below:<br><br><ol><li><strong>Downregulation of receptor expression</strong>. For example, chronic opioid use results in downregulating the number of receptors available to bind the opioid or may increase the degradation or sequestration of receptors. This results in stronger doses of opioids needed to produce the same effect.</li><li><strong>Uncoupling of receptors to secondary messengers</strong>. This is often mediated by proteins called <strong>arrestins</strong>, which bind to G-protein-coupled receptors to prevent interaction with secondary messengers. They can also tag these receptors for endocytosis. <strong>This is common in desensitization (tachyphylaxis)</strong>.</li><li><strong>Exhaustion of intracellular intermediary molecules</strong>. This can occur with drugs such as amphetamines, which eventually leads to the depletion of secondary messengers within cells.</li><li><strong>Increased breakdown of agonists</strong>. For example, this can occur with chronic alcohol use, as &#8220;tolerance&#8221; increases with repeated chronic use due to more rapid degradation of ethanol.</li><li><strong>Physiologic adaptation in the body</strong>. For example, this can occur with thiazide diuretics due to increased activity of the renin-angiotensin-aldosterone system. &#160;</li></ol><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Increased activity of intracellular arrestin proteins:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Increased number of extracellular receptors:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: If more extracellular receptors were available, there would be more binding to the agonist (medication), making it more likely to maintain or increase a cellular response (i.e. drug effect). &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Increased production of secondary messenger molecules:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Since medications/drugs work by binding to a cellular receptor and causing effects via secondary messengers, an increase in secondary messengers is more likely to maintain or increase a cellular response (i.e. drug effect). &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Decreased breakdown of the medication:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Since more medication would be available, this is unlikely to lead to decreased effect. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Decreased sequestration of extracellular receptors:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Decreased sequestration of receptors to bind the medication would result in more receptors available for drug binding, and thus more intracellular changes (i.e. effect) from the medication. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 70-year-old man presents to an outpatient clinic to evaluate shortness of breath and increased swelling of the lower extremities. He states, &#8220;I get so winded after only walking half a city block now that I think my heart failure is worsening.&#8221; Past medical history is notable for heart failure, atrial fibrillation, hypertension, hyperlipidemia, and diabetes. The patient&#8217;s medications include atorvastatin, metformin, metoprolol, rivaroxaban, aspirin, and lisinopril. Temperature is 37.0&#176;C (98.6&#176;F), pulse is 64/min, respirations are 12/min, blood pressure is 174/76 mmHg, and oxygen saturation is 100%. &#160;A beta-blockers examination is notable for bibasilar rales and 3+ pitting edema of the lower extremities. &#160;The patient is subsequently administered a medication that decreases cardiac contractility and increases the release of nitric oxide in the vasculature. Which of the following medications was most likely used to treat this patient&#8217;s clinical condition? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Nebivolol"
        },
        {
          "id": 2,
          "text": "Esmolol"
        },
        {
          "id": 3,
          "text": "Propranolol"
        },
        {
          "id": 4,
          "text": "Diltiazem"
        },
        {
          "id": 5,
          "text": "Epinephrine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient presents with findings suggestive of worsening heart failure. He is started on a medication that decreases cardiac contractility and increases the release of nitric oxide in the vasculature. He was most likely prescribed nebivolol.<br><br>Third-generation &#946;-blockers such as carvedilol, labetalol, and nebivolol carry more than their typical &#946;-blocking effects (e.g., decreased heart rate, decreased cardiac contractility). For instance, <strong>nebivolol </strong>has &#946;<sub>1</sub>-blocking properties, which results in decreased cardiac contractility, and &#946;<sub>3</sub>-<strong>receptor agonism</strong> properties. The latter results in nitric oxide synthase activation in the vasculature and a subsequent decrease in systemic vascular resistance.<br><br>On the other hand, Carvedilol and labetalol have not only &#946;-blocking effects and some &#945;-blocking effects, which lead to vasodilation. This combination makes these drugs exceptionally useful in acute hypertension management and the treatment of heart failure or myocardial infarction. &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Nebivolol:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Esmolol:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Selective &#946;-blockers such as acebutolol, atenolol, betaxolol, bisoprolol, esmolol, and &#160;metoprolol preferentially affect &#946;<sub>1</sub>-receptors, resulting in decreased heart rate and cardiac contractility. However, since these medications do not stimulate &#946;<sub>3</sub>-receptors, they would not induce nitric oxide release. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Propranolol:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Propranolol is a non-selective &#946;-antagonist. It does have agonistic effects on &#946;<sub>3</sub>-receptors and would not induce nitric oxide release. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Diltiazem:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Diltiazem causes vasodilation via calcium channel blockade, not nitric oxide release. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Epinephrine:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Epinephrine is a non-selective &#946;-agonist, which results in increased cardiac contractility and peripheral vasoconstriction. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 57-year-old man with congestive heart failure comes to the office with exertional shortness of breath. He reports that he has to stop to catch his breath after climbing a flight of stairs. He has a history of multiple hospitalizations due to acute decompensation of heart failure with reduced ejection fraction. The patient also has a history of diabetes mellitus and hypertension and is on multiple medications. Temperature is 37.0&#176;C (98.6&#176;F), pulse is 80/min and regular, respirations are 20/min, and blood pressure is 135/85 mmHg. Physical examination shows jugular venous distention, bibasilar lung crackles, and 2+ lower extremity pitting edema. After an appropriate workup, a decision is made to start the patient on digoxin therapy. Which of the following membrane ion channels is the primary target of this drug? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Sodium-calcium exchanger"
        },
        {
          "id": 2,
          "text": "Sodium-potassium ATPase pump"
        },
        {
          "id": 3,
          "text": "Sodium channel"
        },
        {
          "id": 4,
          "text": "L-type calcium channel"
        },
        {
          "id": 5,
          "text": "Potassium channel"
        }
      ],
      "correct_choice_id": 2,
      "solution": "This patient with <strong>heart failure exacerbation</strong> is started on a <strong>positive inotropic medication</strong> (increases the strength of heart muscle contraction), <strong>digoxin</strong>. It acts by <strong>inhibiting the sodium/potassium ATPase pump</strong> at the cell membrane of the cardiomyocyte. Usually, the Na<sup>+</sup>/K<sup>+</sup> ATPase moves two potassium ions into the cell for every three sodium ions out. With digoxin, potassium cannot enter the cell, and sodium can&#8217;t leave it, leading to a <strong>slight increase in intracellular sodium</strong>. The increased sodium alters the driving force for <strong>sodium-calcium exchange</strong> by the exchanger, NCX, so less calcium is removed from the cell. The <strong>increased intracellular calcium</strong> is stored in the sarcoplasmic reticulum. This releases even more calcium into the cell via <strong>calcium-induced calcium release</strong> and <strong>increases contractile force (positive inotropy)</strong>. Digoxin also exerts parasympathetic effects by inhibiting the Na<sup>+</sup>/K<sup>+</sup> ATPase found in vagal neurons' cell membrane, decreasing <strong>heart rate (negative chronotropy)</strong>. <br>&#160;<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/Ref5uITORZWQPGeRr2LOjjqiTZWj7_jT/_.png\"></div><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Sodium-calcium exchanger:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Digoxin does not directly act on the sodium-calcium exchanger but increases its function secondarily by accumulating intracellular sodium ions. &#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Sodium-potassium ATPase pump:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Sodium channel:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Sodium channels in the myocytes are blocked by class I antiarrhythmic drugs (e.g., procainamide, flecainide). They slow the upstroke of sodium-dependent action potentials and usually prolong QRS duration. They are not indicated in heart failure patients. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ L-type calcium channel:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Class IV antiarrhythmics (e.g. verapamil) block the L-type calcium channel in cardiac pacemaker cells to decrease the conduction velocity of the sinoatrial node. These agents should be avoided in heart failure exacerbations. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Potassium channel:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Class III antiarrhythmics block the potassium channels responsible for repolarizing the action potential (AP). This results in an AP prolongation, an increase in the effective refractory period, and a reduced ability of the heart to respond to rapid tachycardias or fibrillation. It can precipitate bradycardia and heart failure and should be avoided in this patient. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 54-year-old woman with nonischemic cardiomyopathy and hypertension comes to the clinic for follow-up following recent hospital admission for acute decompensated heart failure. She becomes short of breath after walking a block but has not had syncope, cough, or hemoptysis. Her current medications include metoprolol, lisinopril, furosemide, spironolactone, and atorvastatin. Her temperature is 37.0&#176;C (98.6&#176;F), pulse is 95/min, respirations are 23/min, blood pressure is 125/85 mmHg, and SpO<sub>2</sub> of 90%. An echocardiogram reveals an ejection fraction of 30%, mild mitral regurgitation, and pulmonary hypertension. BMI is 30 kg/m<sup>2</sup>. Ivabradine is added to her treatment regimen. Which of the following phases of the pacemaker action potential is targeted by this medication? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Phase 0"
        },
        {
          "id": 2,
          "text": "Phase 2"
        },
        {
          "id": 3,
          "text": "Phase 3"
        },
        {
          "id": 4,
          "text": "Phase 4"
        },
        {
          "id": 5,
          "text": "Phase 4 and Phase 0"
        }
      ],
      "correct_choice_id": 4,
      "solution": "This patient presents with symptomatic heart failure (NYHA Class II-III) with reduced ejection fraction and is currently on optimal medical therapy with a diuretic, an ACE inhibitor, aldosterone antagonist, and a beta blocker. Ivabradine is a <strong>selective sinus node inhibitor</strong> that inhibits the funny sodium current that occurs through the HCN channels in the heart's pacemaker cells. As a result, this medication inhibits phase 4 of the cardiac pacemaker action potential.<br><br>Ivabradine is also indicated in the treatment of chronic stable angina in patients with chronic heart failure and a heart rate of &gt;70 bpm. It is not beneficial in those with stable coronary artery disease without heart failure. Adverse effects of ivabradine include symptomatic bradycardia and visual disturbances (presence of phosphenes). <br>&#160;<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/Cw8eeP7vQYaG2OXvDtlu8SrTSJS2DPZf/_.png\"></div><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/GWV0XddzTByVc7wBV9UqSxo0Ske3qvwS/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Phase 0:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Phase 0 depolarization depends on a calcium current via L-type calcium channels. These channels are inhibited by class IV antiarrhythmics like verapamil and diltiazem. Ivabradine does not inhibit L-type calcium channels. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Phase 2:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Phase 1 and 2 of the cardiac action potential are not present in pacemaker cells. Instead, phase 0 proceeds directly to phase 3. Ivabradine acts on cardiac pacemaker cells at phase 0 of their action potential. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Phase 3:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Phase 3 of the pacemaker action potential is governed by the decay of calcium channel current and repolarization driven by rectifying potassium channels. Ivabradine does not affect phase 3 of the pacemaker action potential. &#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Phase 4:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Phase 4 and Phase 0:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Calcium channel blockers affect phase 4 and phase 0, slowing pacemaker potential and delaying depolarization of pacemaker tissue. While ivabradine does act on Phase 4 of the pacemaker potential, it does not affect phase 0 of the pacemaker action potential. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "<span>A 62-year-old man comes to the emergency department following a syncopal episode while at the grocery store.&#160;</span><span>He experienced a sensation of light-headedness and fluttering in his chest before subsequently passing out.</span><span>&#160;The patient&#160;</span><span>states</span><span>&#160;his medical history includes a \"heart condition.\" Brief chart review&#160;</span><span>demonstrates</span><span>&#160;an echocardiogram performed one month ago, which shows a left ventricular ejection fraction of 35%. Temperature is 37.0&#176;C (98.6&#176;F), pulse is 162/min, respirations are 24/min, and blood pressure&#160;</span><span>is 118/82 mmHg. Physical examination&#160;</span><span>demonstrates</span><span>&#160;a hyperdynamic precordium and bibasilar crackles on pulmonary auscultation. Initial ECG shows ventricular tachycardia with left axis deviation. He is&#160;</span><span>subsequently</span><span>&#160;</span><span>initiated</span><span>&#160;on an antiarrhythmic medication and admitted to the coronary care unit. On the second day of hospitalization, he is noted to have a blood pressure of 86/58 mm Hg and jugular venous distention. Laboratory studies show an elevated brain natriuretic protein level. Which of the following medi</span><span>cations is the&#160;</span><span>most likely precipitant</span><span>&#160;of this patient's clinical condition?</span>&#160;",
      "choices": [
        {
          "id": 1,
          "text": "Disopyramide"
        },
        {
          "id": 2,
          "text": "Lidocaine"
        },
        {
          "id": 3,
          "text": "Mexiletine"
        },
        {
          "id": 4,
          "text": "Procainamide"
        },
        {
          "id": 5,
          "text": "Quinidine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "This patient with a history of diminished cardiac output is given an antiarrhythmic agent and subsequently develops findings of acute heart failure. Of the medications listed, only <strong>disopyramide</strong><strong>&#160;</strong>is known to <strong>induce acute decompensated heart failure</strong> in patients with known impaired cardiac contractility. &#160; &#160; &#160; &#160; <br><br>Disopyramide is a<strong>&#160;class IA antiarrhythmic&#160;</strong>that is used most often to treat ventricular arrhythmias and hypertrophic cardiomyopathy. This class of drugs works by <strong>inhibiting voltage-dependent fast sodium channels</strong> in cardiac muscle cells. When an electrical current propagates down the heart and reaches a myocyte, the nearby fast sodium channels typically open and allow a large rush of sodium ions into the cell, quickly raising the charge of the inner cellular membrane from negative to positive. This influx of sodium ions is stopped by the closing of the channel's inactivation gate, which reacts more slowly to the depolarization than to the channel's opening function. &#160; &#160; &#160; &#160; <br><br>By serving as a fast sodium channel blocker in both the atria and the ventricles, disopyramide is able to <strong>slow the speed</strong> at which the heart depolarizes as an organized unit, and also <strong>decrease the strength</strong> of the heart's contractions. As such, one of disopyramide's feared complications is acute heart failure, and thus it cannot be used in patients with impaired systolic function.&#160; &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Disopyramide:</strong><br><span style='opacity:0.9'><span><strong>Correct: </strong></span><span>See Main Explanation.</span>&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Lidocaine:</strong><br><span style='opacity:0.9'><span><strong>Incorrect:</strong></span><span>&#160;Lidocaine is a class IB antiarrhythmic that works by blocking sodium channels and preferentially affects ischemic tissue and Purkinje fibers. Its notable side effects include&#160;</span><span>paresthesias</span><span>, seizures, respiratory depression, and central nervous system depression. However, it would not account for this patient&#8217;s decompensated heart failure.</span>&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Mexiletine:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong><strong>&#160;</strong>Mexiletine is a class IB antiarrhythmic that works by blocking sodium channels and preferentially affects ischemic tissue and Purkinje fibers. Its notable side effect is gastrointestinal upset.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Procainamide:</strong><br><span style='opacity:0.9'><span><strong>Incorrect:</strong></span><span>&#160;Procainamide is a class IA antiarrhythmic that works in the same manner as disopyramide via fast sodium channel blockade. It is a known cause of drug-induced lupus.</span>&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Quinidine:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong><strong>: </strong>Quinidine is a class IA antiarrhythmic that works in the same manner as disopyramide via fast sodium channel blockade. It is known to cause&#160;cinchonism, which is characterized by headaches and tinnitus.&#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 67-year-old woman is brought to the emergency department by her daughter because of progressive dyspnea and confusion for the past two days. Past medical history is significant for ischemic cardiomyopathy, heart failure with reduced ejection fraction (estimated to be 30%), type 2 diabetes mellitus, and hyperlipidemia. The patient reports recent medication nonadherence. Temperature is 37.0&#176;C (98.6&#176;F), pulse is 70/min, respirations are 20/min, and blood pressure is 80/45 mmHg. Physical examination shows elevated jugular venous pressure, bibasilar crackles, an S3 heart sound, and lower extremity edema. The patient is started on intravenous infusion of an agent that increases cardiac contractility and decreases systemic vascular resistance without significant change in arterial blood pressure. Which of the following is an example of this drug? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "High-dose dopamine"
        },
        {
          "id": 2,
          "text": "Phenylephrine"
        },
        {
          "id": 3,
          "text": "Dobutamine"
        },
        {
          "id": 4,
          "text": "Midodrine"
        },
        {
          "id": 5,
          "text": "Norepinephrine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "This patient&#8217;s presentation with worsening dyspnea, confusion, bibasilar crackles, JVD, and an S3, is consistent with severe left ventricular systolic dysfunction and subsequent <strong>cardiogenic shock</strong>. A <strong>dobutamine infusion</strong> is started in this patient to improve cardiac contractility.<br><br>Dobutamine is a beta-agonist, <strong>highly selective</strong> for the <strong>&#946;1 receptor</strong>, coupled to Gs protein, which stimulates adenylate cyclase. This increases cAMP production in the target cells leading to increased activation of protein kinase A (PKA). PKA phosphorylates the calcium channels at the cell membrane leading to an increase in calcium influx into the cells, increasing the force of cardiac muscle contraction (positive inotropy and chronotropy). <br>&#160;<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/vH6iyBlbT4afb8p1wYlzdcpURD2WL1x-/_.png\"></div><br>In the smooth muscle cells (weak &#946;2 effect), increased levels of cAMP cause vasodilation. The net effect is increased cardiac contractility and decreased systemic vascular resistance without significant change in arterial blood pressure.<br><br>Dobutamine is indicated in the management of <strong>acute heart failure</strong> or <strong>cardiogenic shock</strong>. However, it is not appropriate for chronic heart failure because of tolerance, which is when the body adapts to the stimulation from the medication, and gradually the agonist will produce a weaker response. Side effects include tachycardia, palpitations, and even arrhythmias. <br>&#160;<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/3de-JaYkQRC_6Is9AllXapvbSHSq3wv0/_.png\"></div><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ High-dose dopamine:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Dopamine acts on dopamine-1, &#946;1, and &#945;1 receptors. High-dose dopamine primarily acts on alpha-1 receptors leading to increased systemic vascular resistance and blood pressure. Its use should be avoided in this patient. Beta-1 stimulation offsets the reflex-mediated heart rate and remains relatively unchanged. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Phenylephrine:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Phenylephrine is a non-catecholamine with selective &#945;1-agonist activity. The primary effect of phenylephrine is peripheral vasoconstriction with a concomitant rise in systemic vascular resistance and arterial blood pressure. Reflex bradycardia mediated by the vagus nerve can reduce cardiac output. &#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Dobutamine:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Midodrine:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Midodrine is a selective &#945;1-agonist that increases arterial pressure via vasoconstriction with reflex bradycardia mediated by the vagus nerve, which can reduce cardiac output. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Norepinephrine:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Norepinephrine directly stimulates &#945;1 with limited &#946;2 activity (at the doses used clinically) and induces intense vasoconstriction of arterial and venous vessels. It increases myocardial contractility, which contributes to arterial blood pressure. Both systolic and diastolic pressures usually rise, but increased afterload and reflex bradycardia typically prevent any elevation in cardiac output. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "In a large clinical trial, patients with heart failure with reduced ejection fraction (HFrEF) were randomized to study medications A and B. The average left ventricular ejection fraction of study subjects was 30%. Most patients in both groups were concomitantly treated with agents A and B. In the long term, all-cause mortality curves are shown below. The solid line represents agent A, whereas the dashed line represents agent B. The differences between the curves were statistically significant. The dashed line on the graph represents which of the following drugs? <br>&#160;<div><img src=\"https://d16qt3wv6xm098.cloudfront.net/JcVloA_US6yKKmVjRLgeWpSoSc6QB9bO/_.png\"></div>",
      "choices": [
        {
          "id": 1,
          "text": "Spironolactone"
        },
        {
          "id": 2,
          "text": "Lisinopril"
        },
        {
          "id": 3,
          "text": "Losartan"
        },
        {
          "id": 4,
          "text": "Dobutamine"
        },
        {
          "id": 5,
          "text": "Metoprolol"
        }
      ],
      "correct_choice_id": 4,
      "solution": "The dashed line represents an agent that reduced long-term survival in patients with chronic heart failure. In contrast, the solid line represents an agent that improves long-term survival in these patients.<br><br>Medications that improve survival in patients with heart failure with reduced ejection fraction (HFrEF) include beta-blockers, ACEI, ARBs, and mineralocorticoid receptor antagonists.<br><br><strong>Dobutamine</strong>, however, is an inotropic agent, and its long-term use in patients with <strong>chronic heart failure</strong> has been associated with <strong>increased morbidity and mortality</strong>. The same is also true for <strong>milrinone</strong>, a phosphodiesterase-3 inhibitor. Additionally, dobutamine is not appropriate for chronic heart failure because of <strong>tolerance</strong>, which is when the body adapts to the stimulation from the medication, and gradually the agonist will produce a weaker response. Inotropic agents are currently indicated as bridge therapy (to either left ventricular assist device support or transplant) or selectively applied palliation in end-stage heart failure. &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Spironolactone:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Mineralocorticoid antagonists, such as spironolactone, block the deleterious effect of aldosterone on the heart and have been shown to prolong overall survival and hospitalization of patients with HFrEF. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Lisinopril:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Angiotensin-converting enzyme inhibitors such as lisinopril have shown to increase cardiac output, diminish congestive symptoms, reduce the rate of progressive cardiac dysfunction, and decrease cardiovascular mortality in patients with HFrEF. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Losartan:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Angiotensin receptor blockers such as losartan have shown to increase cardiac output, diminish congestive symptoms, reduce the rate of progressive cardiac dysfunction, and decrease cardiovascular mortality in patients with HFrEF. &#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Dobutamine:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Metoprolol:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Certain beta-blockers, including carvedilol, metoprolol succinate, and bisoprolol, have been shown to improve overall and event-free survival in patients with mild to advanced HF. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "<span>A 60-year-old man is admitted to the hospital with enterococcus endocarditis. He is treated with penicillin and gentamicin. During hospitalization, the patient develops worsening pulmonary edema secondary to valvular insufficiency and requires intravenous furosemide therapy. The patient improves over the next few days and is discharged home on the same medications. The patient returns for a routine follow-up visit and notes experiencing muffled hearing and difficulty understanding speech since being dischar</span><span>ged from the hospital. Vitals are within normal limits. Otoscopic examination is unremarkable. Audiometry shows a bilateral symmetrical sensorineural hearing loss. Which of the following is the most&#160;</span><span>likely cause</span><span>&#160;of this patient&#8217;s presentation?</span>&#160;",
      "choices": [
        {
          "id": 1,
          "text": "Squamous cell debris in the inner ear"
        },
        {
          "id": 2,
          "text": "Drug-induced ototoxicity&#160;"
        },
        {
          "id": 3,
          "text": "Stiffening of the ossicles"
        },
        {
          "id": 4,
          "text": "Tumor of&#160;schwann&#160;cells&#160;"
        },
        {
          "id": 5,
          "text": "Scarring of the tympanic membrane"
        }
      ],
      "correct_choice_id": 2,
      "solution": "This patient, who is being treated with penicillin and aminoglycoside, develops decompensated heart failure and receives intravenous furosemide. He subsequently experiences difficulty hearing and bilateral sensorineural hearing loss, which is consistent with <strong>drug-induced ototoxicity</strong><strong><span>.&#160;</span>&#160; &#160;&#160;</strong>&#160; &#160; <br><br><strong>Loop diuretics</strong> (e.g., <strong>furosemide</strong>, bumetanide, torsemide) act on the ascending limb of the loop of Henle by binding and inhibiting the <strong>Na+/K+/2Cl- symporter.&#160;</strong>Inhibition of a similar symporter in the inner ear can cause<strong>&#160;tinnitus, vertigo, hearing impairment,&#160;</strong>and <strong>deafness</strong>. This side effect usually occurs with high doses, rapid intravenous administration, coexisting renal dysfunction, or co-administration with other ototoxic drugs (as in the case of this patient). Ototoxicity is usually reversible after stopping the medication. &#160; &#160; &#160;<br><br>Other side effects of loop diuretics include <strong>hyperuricemia&#160;</strong>and <strong>gout attacks</strong> secondary to increased proximal tubule reabsorption of uric acid. They can also cause<strong>&#160;hypokalemic metabolic alkalosis.</strong> This phenomenon results from an increased concentration of sodium ions in the collecting duct, which leads to increased secretion of potassium and hydrogen ions from the blood into the urine. Finally, the loss of sodium associated with loop diuretic use causes increased excretion of magnesium and calcium, thereby resulting in <strong>hypomagnesemia&#160;</strong>and <strong>hypocalcemia</strong>. &#160; <br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/oIEYY6eoTsyB0GIoOADh6CvFQ5aRNXpd/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Squamous cell debris in the inner ear:</strong><br><span style='opacity:0.9'><span><strong>Incorrect: </strong></span><span>Cholesteatomas are collections of squamous cell debris in the middle ear. Symptomatic patients can present with recurrent otorrhea and conductive hearing loss. In contrast, this patient has&#160;</span><span>a bilateral</span><span>&#160;sensorineural hearing loss after starting furosemide, which is more concerning for drug-induced ototoxicity.</span>&#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Drug-induced ototoxicity&#160;:</strong><br><span style='opacity:0.9'><span><strong>Correct: </strong></span><span>See Main Explanation.</span>&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Stiffening of the ossicles:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong>&#160;Otosclerosis is caused by abnormal bone deposition and results in stiffening of the ear ossicles. Patients typically present with conductive hearing loss and a paradoxical improvement in speech understanding with background noise. In contrast, this patient&#8217;s audiometry testing shows&#160;a sensorineural&#160;hearing loss.&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Tumor of&#160;schwann&#160;cells&#160;:</strong><br><span style='opacity:0.9'><span><strong>Incorrect: </strong></span><span>Acoustic neuromas arise from the Schwann cells covering the vestibular branch of cranial nerve VIII. These patients typically present with asymmetric sensorineural hearing loss. This patient has bilateral sensorineural hearing loss after&#160;</span><span>initiating</span><span>&#160;furosemide therapy, which is more suggestive of drug-induced ototoxicity.</span>&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Scarring of the tympanic membrane:</strong><br><span style='opacity:0.9'><span><strong>Incorrect: </strong></span><span>Tympanosclerosis can cause stiffening of the tympanic membrane and lead to conductive hearing loss. Otoscopic examination often shows chalky patches on the tympanic membrane. In contrast, this patient&#8217;s otoscopic examination&#160;</span><span>is</span><span>&#160;unremarkable.</span>&#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    }
  ]
}